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A BSTR A CT
Tubes containing monoclonal antibodies with anti-neural cell adhesion
molecule (N-CAM)-like activity were applied to transected sciatic nerves to
attempt to perturb the recovery of muscle function.

Physiological recordings

were used to estimate the return of function. The decline of implanted antibody
over 28 days was estimated. No significant immune responses were detected in
response to the implanted material.
Electron microscopic and immunohistological analyses evaluated particular
cellular disruptions in nerves due to the presence of these antibodies with anti-NCAM

like activity.

Histological sections of fixed experimental nerves

consistently revealed abnormal gaps between Schwann cells of regenerating
nerves.

This specific Schwann cell abnormality was not present in nerves of

control animals and was no longer observed in experimental nerves after 60 days
of survival.

This time course was associated with antibody clearance and

restoration of muscle function.

We proposed that perturbed Schwann cell

adhesive interactions disrupted the advance of neurites across nerve gaps and
resulted in delayed regeneration.
contributor to nerve regeneration.

The data implicated N-CAM as a potential

IN T R O D U C T IO N
To regenerate an injured axon, a neuron must undergo a series of
physiological rearrangem ents.

It must reorganize its terminal membrane and

cytoplasm to generate a motile structure called the growth cone, that will move
in a directed manner to appropriate target cells and eventually form a synaptic
terminal.

The neuron must also produce the membrane, cytoplasm and

cytoskeleton required by the elongating and expanding sprout.
In the peripheral nervous system of adult mammals, damaged axons can
regenerate for many centimeters from the site of injury (Ramon y Cajal,
1928a,b).

These regenerating axons are typically found within conduits of

basement membrane and are often in contact with Schwann cells (Hillarp and
Olivecrona, 1946). The basement membrane in the peripheral nervous system,
like many other basement membranes, is comprised of laminin, fibronectin and
other extracellular matrix materials. Purified fibronectin, collagen and laminin
have been shown to stimulate neural outgrowth and to guide nerve processes
under in vitro conditions (Woolley et al., 1990). This growth requires binding
of cell-surface receptors to extracellular matrix adhesive proteins and requires
binding of regenerating axonal sprouts to Schwann cells (Hillarp and Olivecrona,
1946). In the regenerating neurite, there are multiple adhesive systems for both
cell-cell and cell-matrix receptors that are present on neurons, Schwann cells and
fibroblasts (Dellon, 1990).

The neural cell adhesion molecule (N-CAM) is a membrane glycoprotein
that serves as a homophilic ligand in the formation of adhesions between cells
(Hoffman and Edelman, 1933). It is expressed by several types of cells during
embryogenesis including nerve, muscle and glial cells of the developing nervous
system (Edelman, 1984).

N-CAM-mediated adhesion is involved in many

developmental events including axon guidance, segregation of cells into discreet
layers, and the formation and innervation of muscles. M olecular interactions at
the axon-Schwann cell interface that initiate the formation of myelin sheaths
involve N-CAM and LI adhesion molecule. Both N-CAM and L I are present
on the membrane of axons and Schwann cells before the onset of myelination,
but are reduced and weakly detectable after myelination commences (Seilheimer
and Schachner, 1988).
N-CAM is on Schwann cells and their basal laminae and may mediate
Schwann cell adhesion (Daniloff et al., 1986b).

These cells adhere to one

another during regeneration to form cords that guide regenerating nerves through
an injured area. These proliferating Schwann cells align longitudinally within the
confines of the basal lamina or endoneurial tube, creating a continuous column
of cells called the bands of Biingner (Sunderland and Bradley, 1952; Thomas,
1963; Komiyama et al., 1991). Schwann cells also adhere to the basal lamina
as they grow toward the site of injury (Nathaniel and Pease, 1963; Ide et al.,
1983). N-CAM can be detected in the basement membrane of Schwann cells and
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collagen fibrils of the endoneurium (Daniloff et al., 1986a). It has been found
that axon-Schwann cell interactions are characterized by the sequential appearance
of cell adhesion molecules (CAMs) and myelin basic protein coordinated in time
and space.

It was deduced that N-CAM was involved in fasciculation, initial

axon-Schwann cell interactions and the onset of myelination (Daniloff et al.,
1986b).

Two to six days following transection, small diameter regenerating

axons were found to be positive for N-CAM in regions where they made contact
with one another or with Schwann cells. Large diameter axons showed negligible
amounts of N-CAM .

Fourteen days after transection, when regrowing axons

were seen in the distal part of the transected nerve, N-CAM was observed where
regrowing axons made contact with Schwann cells.

Most Schwann cells that

were associated with degenerating myelin also expressed N-CAM.

During

myelination, N-CAM expression is reduced and disappears in compacted myelin
(Mirsky et al., 1986; Martini and Schachner, 1988). N-CAM is also involved
in the initial stages of nerve-muscle contact (Rieger et al., 1985) but is not
essential for the formation of electrophysiologically active synapses.
Overview of Nerve Structure
Peripheral nerve trunks are composed of bundles of neurons, axons and
connective tissue elements. Most nerves contain motor and sensory fibers; the
latter conduct electrical impulses at a faster rate than do motor fibers.

The

presence of myelin profoundly enhances the velocity of impulse transmission.

Each myelinated fiber has a compact myelin sheath, which is composed of a lipid
and protein bilayer. This sheath is formed by a Schwann cell wrapping spirally
around the axon. Individual Schwann cells meet at the nodes o f Ranvier, where
small gaps in the myelin exist.

At these nodes of Ranvier, the axon is

surrounded only by the Schwann cell basal lamina.

Small bundles of

nonmyelinated axons can be encircled by a single Schwann cell, but no myelin
is present (Kuczynski, 1980).
There are three layers of connective tissue in a nerve:

endoneurium,

perineurium, and epineurium. All individual axons are covered by endoneurium.
This covering gives tensile strength to the nerve and promotes resistance to
internal axonal pressure. Bundles of nerve fibers form fasciculi and are encircled
by perineurium. The perineurium can be sutured in order to anastomose severed
nerves (Kline and Kahn,

1982).

Thick, outer connective tissue, called

epineurium, covers the nerve trunk; epineurium has extensions that separate
fasciculi and blend with the perineurium (Kucynski, 1980). This epineurium can
be used to manipulate the nerve during repair and is a frequent site of suture
placement in anastomosis of transected nerves (Sunderland, 1980; Braun, 1982).
Injuries to Nerves
Mammalian peripheral nerve fibers are capable of repair by regeneration
after injury.

Conditions for successful regeneration will be best after nerve

crush; the Schwann cell basement membrane tubes (endoneurial tubes) remain

intact and this gives the injured axons a measure of protection from extracellular
fluid and products of tissue damage at the injury site. The tubes also serve to
contain the Schwann cells needed to support the regenerating axon sprouts and
to guide them into the distal stump and then on to reinnervate peripheral targets
(Horch, 1979; Horch and Lisney, 1981).
Recovery is more likely to occur if axons are simply crushed (Nicholson
and Seddon, 1957) or have a very short (less than 5 mm) interstump gap to cross
(M cQuarrie, 1986). This regeneration distal to the cell body is more likely to
fail if the interstump gap is greater than 1 cm and associated with soft tissue
damage. Even though reactive axonal sprouting is an intrinsic neuronal response
to injury, the subsequent reorganization of these axonal sprouts does not occur
unless Schwann cells are present (Aguayo and Bray, 1980; Lisney, 1989). In
normal, young adult rats sustaining experimental nerve gaps o f 10mm, there are
significant attempts to regenerate and some recovery occurs (Gibson and
Daniloff, 1989b; Madison et al., 1987).
Transection of peripheral nerves causes a breakdown of myelin in the
distal stump. This results in macrophage recruitment to remove myelin debris
from this area.

It has been suggested that these macrophages interact with

Schwann cells and may be a source of Schwann cell mitogens (Scheidt and
Friede, 1987).

During the injury response, Schwann cells proliferate. If the distal stump
is separated from the proximal stump, Schwann cells co-migrate with regrowing
axons. Schwann cells also respond to axonal cues by transient upregulation or
re-expression of molecules which provide a favorable environment for axonal
extension.

They also attract bundles o f regrowing axons and their associated

Schwann cells across interstump gaps up to 1 cm in length (Ramon y Cajal,
1928b).
Schwann cell basal lamina is similar to basal laminae elsewhere, in that
it contains molecules such as laminin and fibronectin, which are potent promoters
o f neurite growth in culture (Rogers et al., 1983; Bozyczko and Horwitz, 1986).
The behavior of Schwann cells inside the basal lamina depends on the presence
of an axon.

The initial breakdown products of axons after axotomy stimulate

Schwann cell multiplication in preparation for phagocytosis o f debris (Aguayo et
al., 1976). Subsequently, a regenerating axon is required for differentiation of
the Schwann cell and production of myelin for the remyelination of the axon by
the Schwann cell. The degree of remyelination is determined by the type of axon
regenerating into the basal lamina (Hillarp and Olivecrona, 1946; W einberg and
Spencer, 1975).
The environment through which axons regenerate in the peripheral nervous
system consists of Schwann cells and their basal laminae, fibroblasts, and
collagen (Seckel, 1990).

Early in regeneration, axonal debris, degenerating

myelin, and phagocytic cells are present (Fawcett and Keynes, 1990; Komiyama
e ta l., 1991). Other factors involved in regeneration include laminin, fibronectin,
collagen, growth and trophic factors, cell-substrate adhesion molecules and cell
cell adhesion molecules (Fawcett and Keynes, 1990).

External factors which

influence regeneration include effects of a conditioning lesion and the affects of
applied pulsed-electromagnetic fields (Aebischer, et al., 1987).

In principle,

functional restorations following peripheral nerve regeneration and target
reinnervation could be accomplished by either random outgrowth and secondary
central adjustments of synaptic connections, or directed outgrowth towards the
‘original’ target areas as well as appropriate target structure reinnervation
(M cQuarrie, 1986). There are indications that specific factors are present in the
distal stump of transected nerves. These factors are thought to attract axons of
the corresponding proximal stump into the distal nerve stump (Ramon y Cajal,
1928a,b).
Nerve Degeneration
Nerve degeneration is a prerequisite for normal motor and sensory axon
regeneration following an injury to a nerve (Bisby and Chen, 1990; Ramon y
Cajal, 1928b).

It leads to the removal and recycling of axonal and myelin-

derived material and prepares the environment through which regenerating axons
regrow. It is influenced by the peripheral connection of the injured nerve and by
the distance the injured section is from the cell body (Gibson et al., 1989a;

Delgado-Lezama and M unoz-M artinez, 1990).

Following axotomy, most

surviving cell bodies undergo a variety of anatomical changes and modifications
in gene expression and cellular metabolism.
The

most

obvious

main

morphological

event

is

chromatolysis.

Chromatolysis reflects a change in metabolic priority from that geared for the
production of neurotransmitters needed for continuous synaptic activity, to the
production of materials for axonal repair and growth. The cell must synthesize
new messenger RNA, lipids and cytoskeletal proteins (Grafstein and M cQuarrie,
1978). This process is characterized by a swelling of the cell soma, formation
of a pyknotic nucleus and the dispersal of Nissl substance (Ramon y Cajal,
1928a,b). The latter is due to the disintegration of large granular condensations
of rough endoplasmic reticulum (Grafstein and M cQuarrie, 1978).
Distal to the site of injury, the severed axon and myelin sheath undergo
Wallerian degeneration (Dyck et al., 1984). The axon, without the continuity of
supporting structures and trophic substances from the cell soma, begins to
degenerate within 12 hours (Stoll et al., 1989). The axon degenerates before the
Schwann cell sheath and becomes irregularly swollen and beaded. The myelin
sheath draws away from the axon and breaks apart.

Both the axon and the

myelin degenerate. Trophic factors accumulate and stimulate Schwann cells to
replicate and move along the endoneurium (Ramon y Cajal, 1928a). Recently
one of these trophic factors is reported to have been isolated (Ratner et al.,

1988). When they reach the site of the initial injury, the Schwann cells fuse with
one another to form columns or bands, classically referred to as the bands of
Biingner (Ramon y Cajal, 1928b). Some Schwann cells also become phagocytic
in response to injury; ingesting fragments of the axon as well as myelin (Bunge,
1980a).
This degeneration continues distally toward the synapse where there is a
progressive loss of synaptic vesicles; the nerve terminal is phagocytized away
from the post-synaptic membrane by Schwann cells and phagocytes. A similar
process occurs in unmyelinated nerve fibers (Lisney, 1989).
Nerve Repair
The two most common methods of surgical repair for injured motor nerves
include direct suturing of nerve stumps for minor injuries and the transplantation
of sensory nerve allografts when large gaps appear. Epineurium can be used to
manipulate the nerve during repair and is the most frequent site of suture
placement for repair of simple nerve transections when no gaps exist between
nerve stumps (Sunderland, 1980; Braun, 1982).

Allografts of sensory nerve

autografts are often used to bridge gaps in severely injured nerves (Gibson et al.,
1989b). Overall results include variable recovery of function and the irrevocable
loss of sensation associated with the removal of a sensory nerve (Kline and Kahn,
1982). The above procedures are attempted to maximize the number of axons
that regenerate through the site of injury and grow back to the correct targets
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(Millesi, 1990). Failure o f axons to regenerate leads to poor sensory recovery
and the innervation of incorrect targets leads to poor m otor control as well as
poor sensory recovery. It has been shown that implants of pure Schwann cells
induce greater numbers o f regenerating axons across nerve gaps than do
autografts (Daniloff et al., 1991).
Excessive tension on the nerve repair is believed to result in decreased
regeneration and reduced overall function.

Tension stretches the endoneurial

tubes and results in physical disruption of nerve fibers, impairment of electrical
conduction and compromise of the blood supply to the proximal and distal stumps
(M iyamoto, 1979).
Sutureless methods of nerve transection repair have been investigated.
These include the use of adhesives to join nerve ends; plasma clots to appose
nerve stumps (Becker et al., 1985), fibrin glue (Kuderna et al., 1979) and carbon
dioxide lasers to weld nerve stumps together (Tupper, 1980).
Entubulization, the implantation of nerve cuffs or guide tubes, has been
shown to be an alternative to direct suture techniques (M olander et al., 1983).
The use of these nerve guide conduits is appropriate for injuries with significant
nerve gaps (daSilva et al., 1985). It is also pertinent for situations where direct
realignment of nerve fascicles is impossible.

Collagen-based nerve guide

conduits are capable of supporting and maintaining axonal outgrowth, extension
and maturation in vivo (Archibald, et al., 1991).
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Regeneration
Contributions of Schwann Cells
The proliferation of Schwann cells during W allerian degeneration and
subsequent regeneration has been well documented (Abercrom bie and Johnson,
1946; Bradley and Ashbury, 1970; Pellegrino and Spencer, 1985; Ramon y
Cajal, 1928b). The first wave of Schwann cell proliferation during W allerian
degeneration occurs 3-4 days after transection followed by an axonal regrowth
stage occurring at 2-3 weeks (Pelligrino et al., 1986). The role of Schwann cells
and hematogenous

macrophages in myelin degradation during W allerian

degeneration of the rodent sciatic nerve has been examined. It was found that
before the appearance of adherent macrophages, the myelin sheath fragments into
ovoids, small whorls of myelin debris appear within Schwann cell cytoplasm and
the Schwann cell displays numerous lipid droplets (Stoll et al., 1989). Myelin
basic protein processed by macrophages was suggested to prom ote the
proliferation of Schwann cells during Wallerian degeneration (Baichwal and
DeVries, 1989). One Schwann cell mitogen has been isolated from regenerating
nerves; this factor is an axonal surface proteoglycan-growth factor complex
(Ratner et al., 1988; Ratner, 1990). The adhesion and proliferation of Schwann
cells is rapidly and transiently induced during W allerian degeneration and this
capacity is maintained longer in the presence of regenerating axons (Komiyama
et al., 1991).
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This loss of axonal contact occurring with W allerian degeneration is
associated with an increased proliferation of Schwann cells (Clemence et al.,
1989). The proliferation of Schwann cells can also be stimulated by contact with
newly regenerating axons or even with fractions of axonal membranes after
Wallerian degeneration is complete (Salzer et a l., 1980; Wood and Bunge, 1975).
If regeneration is prevented, Schwann cells in the distal stump initially bind to
one another to form Schwann cell bands.
Contributions of Conditioning Lesions
An experimental conditioning lesion is a mild injury, usually involving a
nerve compression, that is applied to a nerve prior to a second lesion.

Many

studies have shown that conditioning lesions increase the rate o f regeneration
(M cQuarrie, 1986; Bisby and Pollock, 1983; Bisby, 1985; Oblinger and Lasek,
1984).

This regeneration is associated with expression of genes and proteins

from the cell body. In general, the proteins produced during regeneration are the
same as those associated with axonal growth in embryos.

These substances

include tubulin, actin and growth associated proteins.
There are two main hypotheses regarding peripheral nerve regeneration
after a conditioning lesion (Sjoberg and Kanje, 1990). The first is that the local
environment surrounding the growth cone controls the rate of axonal elongation.
The conditioning lesion causes Wallerian degeneration in the distal nerve, so that
when the test lesion is made the axons are supposed to grow more rapidly along
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pathways vacated by the previously degenerated axons. It is thought that changes
in non-neuronal cells, Schwann cells in particular, and trophic factor production
are responsible for neurite outgrowth (Bray et al., 1978; Salzer et al., 1980).
The outgrowth of neurites starts within 3 hours after a crush injury (Sjoberg and
Kanje, 1990). Therefore, this initial early outgrowth of axons; i.e ., growth cone
formation occurs without support from the cell body.

This suggestion is

supported by the observation that the distal segment of severed axons forms
growth cones in vitro (Bray et al., 1978; Shaw and Bray, 1977; Wessells et al.,
1978).
The second hypothesis is that outgrowth of axonal sprouts is enhanced in
conditioned nerves because they are already activated when the second injury
occurs. It is assumed that the nerve cell bodies have made necessary adjustments
and axons have already synthesized materials necessary for regeneration
(M cQuarrie, 1986; Ducker et al., 1969). It is not clear what signals between cell
body and axon tip regulate the transition to regenerative growth, nor whether
events at the axon tip are controlled in the same way as those at the cell body.
The duration of the effect of the conditioning lesion is also not clear.

An

accepted model for the induction of the regenerative response is that the cell body
invokes changes in a trophic factor normally derived from the target and is
retrogradely transported to the cell body.

However, the earliest regenerative

sprouting at the axon tip can occur within a few hours of axotomy.
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Theoretically, this is too rapid for the cell body to have been informed (Sjoberg
and Kanje, 1990).
Investigators have determined at least two physical mechanisms which alter
regeneration rate: cell body changes and the environment of the injured axons.
Each may act in an additive fashion to produce a maximal conditioning lesion
response (Bisby and Pollock, 1983). The nature of the control exerted by the
axonal environment might be either the provision of providing vacant channels
for axonal growth in the previously degenerated axons, or perhaps provision of
a channel for a diffusible product of degeneration which stimulates the growth of
axons (Bisby and Pollock, 1983).
Superimposition of the conditioning and test lesions on the sciatic nerve
cause a positive reparative effect on motor neurons.

When axons grew into

predegenerated nerves their elongation rate was further increased above that
obtained when the conditioning lesion was distal to the test lesion (Bisby, 1985).
Recovery was accelerated by conditioning, with the entire recovery curve shifted
to earlier time intervals in conditioned nerves, and the initial rate of recovery was
greater. This observation was consistent with a more rapid elongation of axons
along the peripheral nerve trunks and a more rapid invasion of the denervated
muscles. This increased regeneration rate was associated with an earlier recovery
of function (Bisby, 1985).
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Axons also regenerate in vitro much more vigorously from explants taken
during the period of embryonic axonal growth, or from older explants whose
axons have previously been induced to regenerate (Collins and Lee, 1982). The
enhanced regenerative response following a conditioning lesion may be due to the
early availability in the axon of molecules associated with regeneration.
Contributions of Electromagnetic Fields
The influence of electric and electromagnetic fields on growth and
differentiation of nerve tissue in vitro has been reported (Orgel et al., 1984;
Cooper and Schliwa, 1985). The effects of pulsed electromagnetic fields (PEMF)
on nerve regeneration in neurite outgrowth and in animal nerve injury models
have been the subject of many investigations (Orgel et al., 1984; Aebischer et
al., 1987).

In in vitro experiments, cultures treated with PEM F showed

significant increases in neurite outgrowth relative to controls (Sisken et al.,
1990). In vivo exposure to PEM F before lesion production in rat sciatic nerve
produced an increase in axonal sprouting after lesion production (Sisken et al.,
1989a,b). In studies on a nerve crush model, rats placed immediately after injury
in a pulsed magnetic field showed a 22% increase in the rate of axonal sprouting
relative to controls (Wilson and Jagadesch, 1976). This increase was found to
be approximately equal to that obtained with collagen or growth hormone and
was not dependent upon primarily invasive delivery systems.

A comparable

enhancement of regeneration was obtained when the animals were exposed daily
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for seven days before lesioning. This response resembles the response described
for a "conditioning" lesion (M cQuarrie, 1986; Bisby and Pollock, 1983). The
same effect was found in one transection model of rat sciatic nerve in which gait
analysis was performed 4-6 months following transection. In that study PEM F
signals were found to significantly improve perform ance relative to untreated
controls.
Electromagnetic fields were also found to influence the synthesis o f new
polypeptides in a rat sciatic nerve transection model.

PEM F altered the

distribution pattern of polypeptides in the injured nerve. Transection injury alone
changed the pattern indicating a "stress" response. Transection combined with
PEM F reduced the stress response changes, altering the quantitative distribution
o f new polypeptides in the sciatic nerve (Welch et al., 1983).
Contributions of Cell-Substrate Adhesion Molecules
Laminin and Fibronectin
The adhesion of growing neurite processes to collagen or laminin (Bunge
et al., 1980b) is an important determinant of neurite elongation, because growing
fibers orient toward substrates that perm it the greatest adhesiveness, and
preferentially move upon them. Investigators have shown that both fibronectin
and laminin increase the survival of sensory neurons in vitro, and when used in
combination significantly enhanced neurite outgrowth (Baron-Van Evercooren et
al., 1982).
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Laminin is a high molecular weight glycoprotein of MW 850,000 or
greater and is composed o f disulfide-bonded subunit chains o f 400 and 200
kilodaltons. In vivo, laminin has been found in basement membrane throughout
the body, including the glom erular basement membrane, vascular endothelial
basement membrane and the layer underlying the epithelium o f the skin (Foidart
et al., 1980). It promotes the attachment of epithelial cells to Type IV collagen
(Terranova et al., 1980) and can bind to glycosaminoglycans (Del Rosso et al.,
1981).

Laminin

promotes

axon

extension

by

interacting

with

axonal

glycoproteins that are members of the integrin family of receptors. Antibodies
against integrins inhibit the extension of central and peripheral axons on laminin
or extracellular matrix substrates (Tomaselli et al., 1988).
Fibronectin is a high molecular weight glycoprotein of 440 kilodaltons
with two apparently similar disulfide-bonded chains of approximately 220
kilodaltons.

It is found in plasma and is a major component of basal lamina,

connective tissue and the extracellular matrix produced by fibroblasts.

It is

involved in adhesion of cells including fibroblasts and platelets to collagen in
vitro (Ruoslahti et al., 1981). In development, fibronectin may play a role in
muscle morphogenesis and in the spatial organization of cells in the developing
chick wing (Ruoslahti et al., 1981). Surfaces coated with laminin or fibronectin
stimulate a more rapid extension of neuronal processes than do serum or
collagen-coated plastic (Pierce et al., 1988).
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Results from an in vitro study of Schwann cell adhesion and proliferation
showed that Schwann cells from injured nerves possess binding sites for laminin
and fibronectin, which may be partly responsible for the enhanced adhesion of
Schwann cells in vitro (Komiyama et al., 1991). Another in vitro study showed
that neurons induced the laminin mRNA levels of Schwann cells by releasing a
diffusible signal into culture medium (Bunge et al., 1989).

It is thought that

regenerating axons induce the expression of laminin and possibly fibronectin
receptors on Schwann cells (Carey et al., 1983). These receptors are responsible
for the enhanced adhesiveness of Schwann cells in vitro. Laminin and fibronectin
appear to be similar in their ability to promote the adhesion of Schwann cells
from injured nerves at different times after crush or transection injury.
The presence of laminin with little fibronectin in the endoneurium of
mouse sciatic nerve indicates that laminin occurs in vivo in a position where it
may play a role in the regeneration and myelinization of injured axons (Foidart
et al., 1980). Laminin is also present along pathways of axonal growth during
development (Rogers et al., 1983) and regeneration (Hopkins et al., 1985).
The presence of fibronectin in the perineurium (Foidart et al., 1980)
indicates that fibronectin may play a role in the Schwann cell-neuron connective
interactions (Chiu et al., 1991; Martin and Timpl, 1987).
nodes of Ranvier (Terranova et al., 1980).

It is also found at
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A previous study reported that 1)

both fibronectin and laminin are

components of the mature peripheral nerve and are localized in distinct patterns;
2) antibodies to each protein differentially recognize Schwann cells (laminin) and
fibroblasts (fibronectin) in tissue culture preparations; and 3)

laminin is

expressed by the Schwann cell prior to the development of a morphologically
recognizable basal lamina (Cornbrooks et al., 1983).

They also provided

evidence that Schwann cells in culture were capable of synthesizing laminin but
not fibronectin. Cultures of Schwann cell tumors synthesize extracellular matrix
components including fibronectin and laminin (Palm and Furcht, 1983), and it
has been found that added laminin enhances Schwann cell attachment and cell
growth and causes the cells to elongate (McGarvey et al., 1984). The Schwann
cell basal lamina is similar to other basal laminae, in that it contains molecules
such as laminin and fibronectin, which are potent promoters of neurite outgrowth
in culture (Bozyczko and Horwitz, 1986; Rogers et al., 1983). Another study
showed that an in vivo combination of fibronectin and laminin significantly
enhances the regeneration o f myelinated axons across a long nerve gap in the rat
sciatic nerve (Woolley et al., 1990).
N-Cadherin
Cadherins are transmembrane proteins and their cytoplasmic domain is
highly conserved among different members of this molecular family. They are
a molecular family that is essential for the calcium-dependent process of cell-cell

adhesion (Takeichi, 1988).

Their mature form consists of 723 to 748 amino

acids and has a single transmembrane domain that divides the molecules into the
amino-terminal extracellular and the carboxy-terminal cytoplasmic domain
(Shimoyama et al., 1989).

It was observed that cells expressing one type of

cadherin, when mixed with cells expressing another type o f cadherin and cultured
in suspension, tended to aggregate separately (Takeichi et al., 1985).

It is a

reasonable conclusion that cadherins interact with cadherins only in a homophilic
manner (Takeichi, 1990). Cadherin-mediated adhesion is tem perature dependent
(Takeichi, 1990), whereas Ig superfamily-mediated adhesion is not (Hoffman and
Edelman, 1983).
N-cadherin mediates the attachment of neurites to cells on the substratum.
In cell cultures of N-cadherin-transfected cells, a vigorous extension of optic
nerves took place. The growth cones of the axons attached only to the surface
o f transfected cells, and not to a culture dish (Tomaselli et al., 1988).
N-cadherin has a m ajor role in the initial contacts o f nerve growth cones
with Schwann cells (Takeichi, 1988).

Sensory neuronal growth cones on a

laminin substratum were inhibited from migrating onto the upper surfaces of
Schwann cells by soluble antibodies to N-cadherin. This behavior was blocked
reversibly

when

N-cadherin

was

inactivated

by

lowering

the

calcium

concentration o f the culture medium from 1 to 0.1 mM (Volk and Geiger, 1986).
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Retinal growth cones were also blocked from crawling onto Schwann cells
by lowered calcium levels. Electron microscope immunocytochemistry indicated
that N-cadherin is abundant on growth cones, on Schwann cells and at points of
growth cone-Schwann cell contact (Letourneau et al., 1990). The above results
indicate that N-cadherin has a significant role in growth cone migration onto
Schwann cells, since lowered calcium and anti-N-cadherin antibodies reduced
growth cone migration onto Schwann cells.

It functions during the initial

migration of growth cones onto the surfaces of Schwann cells.
Contributions of Cell-Cell Adhesion Molecules
Cell adhesion is one of five prim ary processes of development that include
cell division, migration, differentiation, adhesion and death (Edelman, 1982a).
Cell adhesion is also a critical component o f nerve regeneration (Bunge, 1980a;
Cornbrooks et al., 1983).
Neural Cell Adhesion M olecule (N-CAM1
N-CAM is a high molecular weight cell surface glycoprotein that has been
characterized extensively (Brackenbury et al., 1977; Edelman and Chuong,
1982b; Edelman,

1984; Hoffman et al.,

1982; Rutishauser

1983,1984;

Rutishauser and Goridis, 1986; Edelman, 1983). The basic protein backbone of
rat N-CAM includes three major moieties that m igrate at molecular weights of
115, 135, and 190 kilodaltons on sodium dodecyl sulfate - polyacrylamide (SDSPAGE) gels (Edelman and Chuong, 1982; Hirn et al., 1981). The molecule has
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two forms; the adult (A) form and the embryonic (E) form. N-CAM undergoes
conversion from the E form, with high sialic acid content, to the A form, with
lesser amounts of this sugar, as development progresses. The A form o f N-CAM
contains significantly less sialic acid (Edelman and Chuong, 1982) and increases
the rate of N-CAM binding (Hoffman and Edelman, 1983). This suggests that
this binding may regulate pattern formation and connectivity in the adult nervous
system (Edelman, 1983).
N-CAM is produced from a single gene and is a m em ber o f the
immunoglobulin superfamily (Hemperly et al., 1986b). This group o f proteins
shares a homology sequence o f 100 amino acids connected by a disulfide bridge.
The three polypeptide segments that make up the N-CAM molecule are encoded
by different messengers and are produced by alternative splicing o f a single gene.
They differ mainly in their carboxyterminal part (Hemperly et al., 1986a).
Approximately 98-99% of all brain N-CAM is membrane-associated. In
m uscle, however, a soluble form of N-CAM is synthesized as a prim ary
translation product; its mRNA sequence distinguishes it from the membrane
associated isoforms of N-CAM (Walsh, 1988). At present, little is known about
this soluble N-CAM isoform.
Neurons adhere to other neurons by binding homophilically to the N-CAM
on their respective surfaces (Hoffman and Edelman, 1983). In the em bryo, NCAM binding contributes to these processes; neural induction (Chuong, 1990),
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neurite outgrowth (Rutishauser e ta l., 1978; Rutishauser and Jessell, 1988; Chang
et al., 1987), formation of retinal layers (Buskirk et al., 1980), nerve-muscle
interactions (Grumet and Edelman, 1984), the ensheathment o f axons (Rieger et
al., 1988) and the formation o f synapses (Sanes, 1989). N-CAM is present from
the blastoderm stage in chicken (Crossin et al., 1985) and is present on most
cells in the brain with a relatively uniform distribution (Persohn and Schachner,
1987).

N-CAM is present on all neurons examined in both the central and

peripheral nervous system (Thiery et a l., 1982; M irsky et a l., 1986).

In the

peripheral nervous system, N-CAM is present on non-myelinating Schwann cells,
nodes o f Ranvier (Rieger et al., 1986), and on satellite cells o f sensory and
sympathetic ganglia (Mirsky et al., 1986).
Cell-cell binding occurs through a series of cell surface modulatory events
that alter N-CAM affinity, prevalence, mobility and distribution on the surface
(Cunningham et al., 1987). These signals appear to be triggered by local signals
produced by developing cells (Crossin et al., 1985).

Local signals between

neurons and glia may regulate CAM expression in the spinal cord and nerve
during regeneration, and that activity may regulate N-CAM expression in muscle
(D aniloff et al., 1986b).
In the brain, N-CAM has been shown to mediate calcium-independent
neuron-neuron, astrocyte-neuron and astrocyte-astrocyte adhesion (Keilhauer et
al., 1985). Outside the nervous system, N-CAM mediates interactions between
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several cell types, including nerve-muscle cell interactions (Rutishauser et al.,
1983). The adhesive activity has been demonstrated primarily through N-CAM
antibody perturbation assays.
In mature tissues, N-CAM may be a local signal for reformation of nervemuscle contacts following peripheral nerve injury (Daniloff et al., 1986b; Rieger
et al., 1988; Doherty et al., 1991). Local production o f the embryonic (E) form
o f N-CAM , which is rich in polysialic acid, may modulate axon regeneration in
an injured nerve (Edelman and Chuong, 1982; D aniloff et al., 1986a; Friedlander
et al., 1985; Landmesser et a l., 1990).
The expression of N-CAM has been found to increase in response to nerve
compression and transection, especially near an injury. Specifically it has been
found to increase more in the proximal than the distal stump, where only the E
form has been isolated.

Immunohistological localization indicated that both

Schwann cells and axons contain it (Daniloff et al., 1986b).
One study found that non-myelinating Schwann cells formed slender
processes which were N-CAM positive in the regenerating adult mouse sciatic
nerve during and after degeneration of axons (the first 2-6 days) (Martini and
Schachner, 1988).

Only a few myelinating Schwann cells expressed N-CAM .

Growth cones and regrowing axons expressed N-CAM at contact sites with
fibroblast-like cells on the cut ends of nerve stumps. Regrowing small diameter
axons were N-CAM positive where they contacted each other or contacted
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Schwann cells.

Schwann cells associated with degenerating myelin also

expressed N-CAM (Martini and Schachner, 1988).
The presence of extracellular N-CAM near an injury suggests that its
secretion could be an attractant for neurites or migrating Schwann cells.

The

localization of N-CAM on Schwann cells indicates that N-CAM could affect
Schwann cell proliferation, a component o f the peripheral nervous system ’s
response to injury (Kruse et a l. , 1984). N-CAM is also a component of the basal
lamina (Rieger et al., 1988) and shares a common epitope with myelin-associated
glycoprotein (Madison et al., 1987); this indicates that N-CAM may indirectly
be involved in myelin formation.
Contributions of Trophic Factors
Trophic factors and their receptors are extracellular signals involved in the
regulation of normal and injury-induced neurite outgrowth. It has been implied
that peripheral effector organs produce limiting amounts of specific neurotrophic
factors to ensure proper innervation of targets by appropriate neurites (Korsching
and Thoenen, 1983).

These factors are necessary to maintain the normal

metabolic, functional and neurochemical state of the functional axon.
Nerve Growth Factor (NGF)
Nerve growth factor is the only defined molecule for which a chemotropic
role has been postulated. In vitro, the growth cones o f sensory neurons orient
toward a source of NGF (Gundersen and Barrett, 1979). There are changes in
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the quantities of NGF and its receptor in regenerating nerves (Heumann et al.,
1987). Very little NGF or NGF receptor is found in a normal peripheral nerve.
However, if the nerve is cut or crushed, the level of both molecules and their
respective mRNAs in the region distal to the injury increases enormously. The
expression of NGF receptor by Schwann cells is probably controlled by axonal
contact, and decreases when axonal contact is restored (Taniuchi et al., 1986).
In one study: (1) the NGF receptor molecules were localized to the cell
surface of Schwann cells forming bands of Bungner, (2) axonal regeneration in
the distal portion of the sciatic nerve coincided temporally and spatially with a
decrease in Schwann cell production of NGF receptor, (3) Schwann cell NGF
receptors could be induced by axotomy o f NGF-independent neurons, such as
motoneurons and parasympathetic neurons, and (4) the presence of axon-Schwann
cell contact was inversely related to expression o f NG F receptors by Schwann
cells (Taniuchi et al., 1988).

When Schwann cells are released from axonal

contact, they express NGF receptors on their surface and also secrete NG F. This
NG F receptor expression and NGF secretion by Schwann cells also occurs
extensively in nerves undergoing active degeneration, and subsides again when
nerve regeneration is completed.

NGF is actually a potent modulator for

increasing neurite sprouting from adult rat dorsal root ganglia (DRG) in culture
(Taniuchi et al., 1986).
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Beta-nerve growth factor (B-NGF) supports the differentiation, maturation
and survival of sympathetic and primary sensory neurons (Thoenen and Barde,
1980; Raivich et al., 1989). It is bound by NGF receptors, synthesized on the
surface of neurites, internalized and then transported to the neural perikarya
where it exerts its neurotrophic effects. Injury to a peripheral nerve results in a
biphasic increase in the endoneural mRNA coding for B-NGF, leading to an
increase in the local synthesis of B-NGF protein (Heumann et a l., 1987).
Peripheral axotomy also leads to a highly reproducible disappearance of
neuronal B-NGF receptors (Taniuchi et al., 1986).

Following transection or

crush of the sciatic nerve, B-NGF receptors disappear from the chromatolytic
neuronal perikarya in the axotomized DRG by 6 days post-injury (Raivich and
Kreutzberg, 1987). This decrease is greater after nerve transection than after a
nerve crush. There is a concomitant decrease in retrograde axonal transport o f
endogenous NGF during sciatic nerve regeneration but the decrease stabilizes at
a level 33% of normal control values (Raivich et al., 1989). This decrease in
retrograde transport corresponds to a decrease in B-NGF in the proximal part of
the regenerating sciatic nerve. With peripheral reinnervation there is a gradual
increase in the axonal expression of B-NGF receptors and B-NGF retrograde
transport.

Both these values reach normal levels 30-40 days after the injury

(Korsching and Thoenen, 1983).

28
Insulin-like Growth Factor-1 (IGF-1)
Insulin-like growth factor-1 has growth-stimulating activity and is believed
to mediate some of the actions of growth hormone (Froesch et al., 1985). IG F’s
prom ote neurite outgrowth in cultured sensory and sympathetic neurons (RecioPinto, 1986), spinal cord (Ishii et al., 1989) and cloned human neuroblastoma
cells (Recio-Pinto and Ishii, 1984, 1988). IGF-1 also stimulates proliferation and
growth associated with nerve regeneration (Froesch et al., 1985; Kanje et al.,
1989; Sjoberg and Kanje 1989; Hansson et al., 1986).
Physiological concentrations o f IGF-II can also support the long-term
survival of peripheral neurons in culture (Recio-Pinto, 1986; Recio-Pinto and
Ishii, 1988).

One hypothesis is that IGF-1 produced by Schwann cells in the

distal nerve segment is taken up by the regenerating nerve fibers. Internalized
IGF-1 is then transferred to the nerve cell body by retrograde axonal transport.
In the cell body, IGF-1 initiates or enhances the regenerative process, possibly
by stimulating lipid and protein synthesis (Kanje et al., 1990).
Growth Associated Protein (GAP 43)
B-50/GAP-43 is one of a small subset of cellular proteins selectively
transported by a neuron to its terminals (Skene and W illard, 1981).

Its

enrichment in growth cones and its increased levels in developing or regenerating
neurons suggest that it contributes to neurite growth (Verhaagen et al., 1988).
In adult rat DRG, crush lesions of the sciatic nerve result in a rapid expression
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of B-50/GAP-43 mRNA followed by synthesis of B-50/GAP-43 protein and
transport into the newly formed sprouts (Gispen et a l., 1990a).

Normal

neuromuscular junctions of the soleus muscle, one of the target muscles of the
sciatic nerve, rarely contain GAP-43. During reinnervation following damage,
neuromuscular junctions contain abundant amounts of GAP-43; these levels
return to normal after completion of reinnervation (Gispen 1990a).
The precise function or mechanism of action of B-50/GAP-43 in
developing, regenerating and adult peripheral and central nervous system neurons
is still not clear. The recognition that the protein is a substrate for protein kinase
C and that phosphorylation reduces its ability to bind calmodulin suggests that
this protein is involved in a transmembrane signal transduction mechanism
(Gispen et al., 1990b). In the regenerating neuron, the axonal growth cone is
enriched in B-50/GAP-43 and may need this protein either as a buffer o f
calmodulin or as a regulator in the polyphosphoinositide response to external
signals that guide motility (Gispen et al., 1990a).
Ciliary Neurotrophic Factor (CNTF)
The large quantities of ciliary neurotrophic factor present in the sciatic
nerve o f adult rats suggest the possibility of its function as a ’lesion’ factor
preventing motoneuron degeneration after nerve lesion (M anthorpe et al., 1986;
Stockli et al., 1989). This suggestion is supported by the following observations:
1) transection of the facial nerve in adult rats, which contain almost exclusively
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axons of motoneurons, results in chromatolysis in the motoneuron cell bodies;
however, no degeneration of facial motoneurons occurs within 1 week (Tetzlaff
et a l., 1988), 2) transection of the facial nerve in newborn animals results in
a degeneration of all neurons (Sendtner et al., 1990). The extent of degeneration
decreases rapidly in the postnatal period and parallels the increase in levels of
CNTF in the peripheral nerves (Stockli et al., 1989).

The fact that the local

administration of CNTF in newborn animals can almost completely prevent the
degeneration of the corresponding motoneuron cell bodies supports the validity
o f a causal relationship between the extent of degeneration and the levels o f
CN TF in lesioned nerves (Sendtner et al., 1990).

OBJECTIVES OF THIS STUDY
Recent studies suggest cell interactions mediated by N-CAM may
contribute to the regeneration of injured nerves and the reinnervation of target
muscles (Daniloff et al., 1986b; Rieger et al., 1985; Rieger et al., 1988). For
example, anti-N-CAM antibodies have been used in vivo to perturb the formation
of the retinotectal pathway in Xenopus (Fraser et al., 1984) and to perturb retinal
lamina formation in chick embryos (Buskirk et al., 1980).

The terminal

Schwann cell was not found in the area of nerve-muscle contact when N-CAM
antibodies were present (Grumet et al., 1982). N-CAM antibodies also perturbed
nerve-muscle interactions (Rieger et al.,

1985).

The present study was

undertaken to discover any underlying cell adhesion mechanisms that were
blocked by attaching implants containing antibodies with anti-N-CAM like
activity to injured nerves.
My primary goal was to describe any disruptions in the time course o f in
vivo muscle reinnervation that resulted when binding was blocked by monoclonal
antibodies with anti-N-CAM like activity. These I will refer to henceforth as our
antibodies.

Tubes containing our antibodies were microsurgically attached to

both stumps of transected sciatic (ischiatic) nerves.

The entubulization model

was based upon previously published observations of enhanced nerve regeneration
with the implantation of inert tubes (Fields and Ellisman, 1986; Madison et al.,
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1987; LeBeau et al., 1988; Gibson et al., 1989a,b), collagen (Bunge, 1980a),
laminin (Madison et al., 1987) or gangliosides (Mengs et al., 1984).
Non-invasive muscle-evoked potentials were recorded to assess return of
nerve function (Kline and Kahn, 1982). Enzyme-linked immunosorbent assays
(ELISAs) were used to test sera for systemic immune responses to the implants
and to estimate the amount o f our antibody that remained in them.
Inert, plastic tubes containing our antibodies were microsurgically attached
to the stumps of transected sciatic (ischiatic) nerves to span a gap of 4 mm.
Control implants contained Thy-1 antibodies. In adult rodent brain Thy-1 occurs
on almost every neuronal surface, and immunohistochemical labeling stains
virtually all nervous tissue; peripheral nervous system axons have nearly twice
the surface density of Thy-1 as central nervous system axons (M orris and
Grosveld, 1989).

Thy-1 antigen represents a model system for analyzing the

properties of cell membrane structures shared between brain and lymphoid cell
lineages (Naquet et al., 1989).

Both light and electron microscopic analyses

were used to examine cellular interactions that occurred during sciatic nerve
regrowth across the 4 mm nerve gaps.

METHODS
A ntib od y P roduction

Immunization
A monoclonal antibody against rat N-CAM was prepared using young
adult female, Balb/C mice. The Louisiana State University centralized Tissue
and Organ Culture Facility was utilized for these procedures. Initially mice were
immunized intraperitoneally with 500 pi of saline containing 20 pg of purified
rat N-CAM (obtained as a generous gift from the Edelman Laboratories,
Rockefeller University, New York, NY) and 2 x 109 killed Bordetella pertussis
organisms (Wako Chemicals, Dallas, TX). Subcutaneous booster immunizations
for each mouse contained 10 pg live, dissociated embryonic rat brain cells (Hirn
et al., 1981) which were given on three occasions at 14 day intervals. The mice
were killed three days after the final booster immunization and their spleens were
recovered for the production of monoclonal antibodies (Oi and Herzenberg,
1980).
Isolation
The spleens from the immunized mice were aseptically harvested, placed
in a petri dish containing complete Dulbecco’s Modified Eagle’s medium. This
medium was injected into the spleen, causing it to swell and cells to be released.
The tissue was teased apart with dissecting needles to release as many cells as
possible.

These cells were then centrifuged for 5 minutes at 200 x g.
33
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supernatant was removed from the pellet and the pellet was resuspended in Geys
hemolytic medium. This mixture was allowed to stand at room temperature for
exactly 5 minutes, then centrifuged for 5 minutes at 200 g.

The cells were

resuspended in 10 ml complete medium at room temperature. Hybridoma cells
were selectively grown using standard techniques (Kohler and M ilstein, 1975,
1976; Kohler et al., 1976). The myeloma cell line (SP2/0-M 14) was expanded.
Spleen cells and partner cells were washed, harvested, and mixed.
Fusion
Cell fusion was performed at 37°C in the presence of polyethylene glycol
(PEG).

Cell count and viability of the myeloma cell were determined and a

volume containing 2 x 107 cells was centrifuged at 200 x g for 5 minutes. Cell
count and viability was also determined on the spleen cells.

A volume of

myeloma cell suspension was added to the spleen cell suspension (the spleen
cell/myeloma cell ratio was 10:1).
minutes at 200 g.

This cell mixture was centrifuged for 5

The resulting pellet was harvested and plated into tissue

culture plates. After incubation with hypoxanthine, aminopterin, and thymidine
(HAT) medium and feeding over 2 weeks, the hybridomas were screened.
Two hundred sixty-four clones were isolated. By screening these clones,
we determined that five had the capacity to recognize N-CAM as described by
Edelman and Chuong (1982b) and by Chuong and Edelman (1985). An enzymelinked immunosorbent assay (ELISA) procedure developed for the detection of
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N-CAM antibodies (Chuong and Edelman, 1985) was one method used to screen
the clones. The clones were also tested on W estern blots against embryonic rat
brain membrane extract (Appendix G).
Antibody Screening
N-CAM Enzvme-Linked Immunosorbent Assay Procedure
For each 96 well polyvinyl plate, 50 /x1 of N-CAM solution was applied
to each well. This solution contained 1 mg rat N-CAM in 4.8 ml ELISA buffer
(EPBS, Appendix B). Plates were incubated at 37°C until dry, and were fixed
for 5 minutes with 100% methanol. After drying, plates were incubated at room
temperature in EPBS plus 10% NGS for 1 hour to block non-specific binding.
Then 1 /d of culture supernate from each clone was applied to each well in 50
H1 EPBS (supplemented with 10 mg/ml bovine serum albumin).
incubated overnight at 4°C.

Plates were

After washing three times in EPBS, plates were

incubated in goat anti-mouse IgG (Sigma Chemical C o., St. Louis, MO) and
horse anti-goat IgG conjugated to horseradish peroxidase (HRP) (Sigma Chemical
Co.). Diaminobenzidine (Vector Laboratories, Inc., Burlingame, CA) was added
to visualize the HRP. To estimate the affinity of each antibody to N-CAM , each
plate was scanned colorimetrically in an ELISA reader (Dynatech Laboratories).
Antibodies from four clones showed high positive affinity for the N-CAM antigen
on their particular well (Appendix G).

These were considered potential

antibodies that recognize N-CAM and N-CAM-like proteins.

36
Determination of Recognized Protein M olecular Weights
Brains were dissected from 19 day rat fetuses and homogenized in
calcium/magnesium-free (CMF) medium containing Aprotinin (200 units/ml;
Sigma Chemical Co.). Plasma membranes were enriched by a one-step sucrosegradient. Material from the surface interface was extracted with PBS containing
0.5% Nonidet P-40 and 1 mM EDTA. Aliquots (50 /xl) of material in solution
(containing 100 /xg protein as determined by the BCA* protein assay) were
resolved on 8.5% SDS polyacrylamide gels (Laemmli, 1970). Gel lanes were
transferred to nitrocellulose membranes (Towbin et al., 1979) and cut into
individual vertical strips. Individual nitrocellulose strips were then incubated for
4 hours with the radiolabelled antibodies (3 jug/ml PBS-BSA) and washed three
times. After the Kodak SB-5 X-Ray film that had been aligned with the gel at 70° for 1 month was developed and fixed, radiolabelled proteins were visualized
(Friedlander et al., 1985).
Antibody Isotvping
The clones were isotyped using a commercial kit (Sangstat C o., ISOSTAT
Ab Kit, Palo Alto, CA).
exactly.

Instructions included with the kit were followed
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A n tibody Purification

Anion Exchange Chromatography Purification
Anion Exchange Chromatography Purification (Fahey and Terry, 1979;
Sober and Peterson,

1958). Pre-swollen anion exchange DE52 cellulose

(Whatman Specialty Products Inc., Fairfield, NJ) was used to purify the cell
culture supernatant. About 15-30 ml of buffer are used for every dry gram of
cellulose initially taken, or about 6 ml/g of wet ion exchanger. Two hundred
grams of preswollen DE52 cellulose was stirred in 500 mis of 10X 0.175 M
N a P 0 4 for 13 minutes. The buffer was decanted off and replaced with IX
0.175 M N aP 0 4, stirred and allowed to settle. The slurry was allowed to settle
and the supernatant was decanted. This step was repeated 3 times and the slurry
was allowed to settle. The pH of the buffer/ion exchanger slurry was adjusted
to 8.6 with IN NaOH while stirring. This stirred slurry was then swirled and
poured into a C26/40 column (Pharmacia, LKB; Catalog No. 19-5201-01) and
was allowed to pack and fill the column.
The cell culture supernatant was dialyzed for 24 hours against the 0.175
M N a P 0 4 buffer, pH 8.6 for 48 hours with changes 4 times daily. This mixture
was then loaded onto the column at a flow rate of 1.0 ml/min. The elution of
the sample was performed immediately using IX 0.175 M N a P 0 4 pH 8.6
followed by IX 0.175 M NaPG4 with 0.05 M NaCl added. Absorbance at 280
nm was measured and total protein was determined by the Pierce bicinchoninic
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acid (BCA*) protein assay (Pierce, Rockford, IL; catalog #23220/23225, batch
900403081) (Redinbaugh and Turley, 1986); the presence o f IgG was confirmed
by gel electrophoresis.
Protein-A Purification
Protein-A Purification (Ey et al., 1978; Lindmark et al., 1983, Richman
et al., 1982) - To attempt Protein-A purification of our monoclonal antibody, a
HiTrap™

Protein A Sepharose High Performance affinity column from

Pharmacia LKB was used.

This was a prepacked, ready-to-use, disposable

column for purification and isolation o f monoclonal and polyclonal IgG from
ascites, serum and cell culture supernatants. The cell culture supernatant was
centrifuged at 10,000 x g for 10 minutes and filtered (0.22 /im), then dialyzed
against the start buffer (50 mM Tris buffer, pH 8.6) for 24 hours with 4 changes
of buffer. The column was washed with 5 volumes of start buffer; the sample
was applied to the column and allowed to flow through. The column was washed
with 10 volumes of start buffer before elution with 0.1 M citric acid, pH 3.0.
Aliquots (1 ml) were collected into tubes containing 1/10 volume of 1.0 M TrisHCL neutralization buffer, pH 9.0. Absorbance at 280 nm was measured and
total protein was determined by the Pierce bicinchoninic acid (BCA515) protein
assay

(Pierce,

Rockford,

IL;

catalog

#23220/23225,

batch

900403081)

(Redinbaugh and Turley, 1986); and the presence of IgG was confirmed by gel
electrophoresis.
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Protein-G Purification

Protein-G Purification (Akerstrom et al., 1985; Bjorck and Kronvall,
1984) - MAb-Trap™ G from Pharmacia LKB Biotechnology, Inc., Piscataway,
NJ was used to attempt protein-G purification of IgG. This column was designed
for quick and effective purification of monoclonal and polyclonal IgG from
ascites fluid, serum and cell culture supernatants. The cell culture supernatant
was centrifuged at 10,000 x g for 10 minutes and filtered (0.22 /xm).

The

column was equilibrated with 0.2 M sodium phosphate (pH 7.0) (binding buffer);
the prepared sample was applied to the top frit and absorbed onto the gel.
Unbound proteins were washed away with the same binding buffer. The bound
IgG was eluted with a pH 2.7 elution buffer (1.0 M glycine-HCl) and collected
into tubes containing 1/10th volume of a pH 9.0 neutralization buffer (1.0 M
Tris-HCL).

Absorbance at 280 nm was measured and total protein was

confirmed by the Pierce bicinchoninic acid (BCA*) protein assay (Pierce,
Rockford, IL; catalog #23220/23225, batch 900403081) (Redinbaugh and Turley,
1986); and the presence of IgG was confirmed by gel electrophoresis.
Avid AL™ Purification
Avid AL™ Purification (Khatter et al.,

1991; Fuglistaller,

1989;

Gassmann et al., 1990) - Avid AL mini-columns from BioProbe International,
Inc., (The Nest Group, Southborough, MA) were used to attempt the purification
o f the IgG from cell culture supernatant.

Avid AL is a novel affinity gel
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specifically designed to bind immunoglobulins from mammalian and avian
species. It will also purify mouse monoclonal antibodies from hybridoma cell
supernatant or ascites fluid (Khatter et al., 1991; Fiiglistaller, 1989). All these
immunoglobulins will bind to Avid AL under physiological saline conditions.
The column was prepared by washing with 15 ml of a regeneration buffer (20
parts methanol, 80 parts 1% acetic acid) followed by equilibration by washing
with 10 ml of a 0.01 M sodium phosphate buffer, pH 7.4 (PBS).

The cell

culture supernatant was centrifuged and filtered through a 0.22 fxm filter. The
pH of the hybridoma supernatant was then adjusted to a pH of 7.3. Three ml
were applied to the column and allowed to flow through. The column was then
washed with the PBS buffer until all the Phenol Red dye was removed.

The

sample was eluted with a pH 2.8, 0.05 M sodium acetate buffer containing 20%
glycerol into tubes containing a 1/10 volume of 1 M Tris base buffer, pH 11.0.
Absorbance at 280 nm was measured and total protein was confirmed by the
Pierce bicinchoninic acid (BCA*) protein assay (Pierce, Rockford, IL; catalog
#23220/23225, batch 900403081) (Redinbaugh and Turley, 1986); and the
presence of IgG was confirmed by gel electrophoresis.
Antibody Characterization
Western Blot Procedure
1.

Preparation of Rat Embryo Brain Membrane Extracts for Transfer

to Nitrocellulose - Brains were removed from 19-day rat embryos and washed
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with cold calcium-magnesium free (CMF) media. The tissue was homogenized
in a Dounce homogenizer containing CMF supplemented with 200 units/ml of
aprotinin (a protease inhibitor, Sigma Chemical Co.).

The homogenate was

centrifuged for 20 minutes at 15,000 rpm in a Beckman centrifuge (JA20 rotor)
at 5°C.

This step was repeated.

The pellets were resuspended with 2.25 M

sucrose in PBS buffer, 18 mis were placed in centrifuge tubes and each aliquot
was overlaid with 8 mis of 0.8 M sucrose in PBS. These tubes were centrifuged
for 1 hour at 100,000 rpm, 4°C in a Sorvall centrifuge (TD-65 rotor).

The

material at the interface between the two sucrose concentrations was collected and
washed twice with PBS. The above membranes were suspended in an extraction
buffer [10 mM Tris, 5 mM EDTA (pH 8.2) plus Nonidet P-40] and centrifuged
for 40 minutes at 100,000 rpm, 4°C.
2.

Sodium Dodecyl Sulfate - polyacrylamide gel electrophoresi

(SDS-PAGE) was carried out as previously described (Laemmli, 1970).

Gels

were 7.5% acrylamide and samples of rat brain membrane extract were prepared
by boiling for 3 minutes with mercaptoethanol.

Gels were calibrated with the

following protein standards: Rabbit skeletal muscle myosin (Mr = 200,000), E.
coli 6-galactosidase (Mr = 130,000), Rabbit muscle phosphorylase b (Mr =
94,000), Bovine serum albumin (Mr = 68,000), and Hen egg white ovalbumin
(M,. = 43,000) (Bio-Rad SDS-PAGE Molecular Weight Standards, High and
Low Range, Richmond, CA).
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3.

Sample Transfer to Nitrocellulose - The electrophoretic

transfer of proteins from polyacrylamide gels to nitrocellulose sheets was
performed according to the method of Towbin et al., 1979 (Appendix B).
4.

Autoradiographic Visualization of Proteins Recognized by

Monoclonal Antibodies to rodent N-CAM - Nitrocellulose sheets were incubated
for three hours in monoclonal antibody solution (0.4 mg antibody in saline) for
three hours.

This antibody with anti-N-CAM like activity was semi-purified

from cell culture supernatant as described (Greenberg and Edelman, 1983).
Proteins recognized by the antibody were visualized after lanes were incubated
with goat anti-mouse IgG (0.4 mg/ml in saline; Sigma Chemical Co.) and horse
anti-goat IgG conjugated to [3H]-thymidine (Dupont Co., NEN Research
Products, Boston, MA). Gels were treated with sodium salicylate (Chamberlain,
1979) for autoradiography.

Gel blots were dried and exposed at -70°C (one

month) to Kodak SB-5 x-ray film.

Developed films indicated the molecular

weights of proteins recognized specifically by this antibody. Control lanes, not
incubated in any primary monoclonal antibodies were negative.
Retinal Perturbation Assay
For this assay, retinal fragments from 6 day old chick embryos were
dissected from the region surrounding the choroid fissure; these were positioned
with their vitreous side down on 1/4 of a 2 cm Millipore filter, 1.2 fxm pore size,
that had been wetted with medium and placed on a stainless steel grid in a tissue
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culture dish. The medium was Dulbecco’s modified Eagle’s medium (DMEM),
supplemented with 10% volume of heat-inactivated fetal calf serum (LSU School
of Veterinary Medicine Tissue Culture Facility).

The purified IgG from cell

culture supernatants of the clones 3D12A, 3B1A and a commercial antibody (Rat
anti-Neural

Cell

Adhesion

Molecule

Monoclonal

Antibody,

Chemicon

International, Inc., Temecula, CA; catalog it MAB310, Rat IgG2a) were
dissolved in tissue culture medium to a concentration of 1 mg/ml. All cultures
were carried out for 3 days at 37°C in an atmosphere of 5% C 0 2, and the retinae
were then fixed in 2.5% formaldehyde/0.2 % glutaraldehyde in PBS for paraffin
embedding.
Implant Preparation
Sterile tubes, 6 mm in length, were prepared o f inert silastic (inner
diameter 0.78 mm, outer diameter 1.25 mm; Dow Corning). For experimental
animals, each tube contained 2.5 /zg monoclonal antibody (3B1A) mixed with 20
jx1 of bovine collagen gel (Collagen Corp, Palo Alto, CA).

Control animals

received tubes containing 20 /x\ of collagen gel with 2.5 fxg of monoclonal
antibody to Thy-1 protein (Miles Corp), a neuronal surface protein (Campbell et
al., 1981; Letarte, 1984).
Surgery and Survival Times
Young adult female Sprague-Dawley rats weighing approximately 200 gm
were anesthetized by intraperitoneal injection of chloral hydrate (8%; 0.33 ml/kg
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body weight). One sciatic nerve was exposed from the sciatic notch to the tibialperoneal bifurcation and transected at mid-thigh level. The proximal and distal
stumps were attached to the ends of the 6 mm silastic implant with 9.0 silk suture
(Ethicon Inc., Somerville, N.J.). Implants spanned a gap of 4 mm between the
two stumps. The sciatic compartment was closed with 3.0 gut suture (Ethicon
Inc.) and the skin was closed with 3.0 nylon (Ethicon Inc.). The contralateral
limb was not manipulated, it served as the normal control for each animal.
Tubes were implanted into 34 rats. Twenty-five animals were used for
physiological assessment and necropsy at 10 (n = 7), 20 (n = 6), 30 (n = 6), or 60
(n = 6) days of survival. These same animals from 10, 30 and 60 days were used
for the morphology part o f this study.

The survival period of 10 days was

chosen because it was found that chromatolysis, a product of Wallerian
degeneration, was complete at this time (Ramon y Cajal, 1928b). Thirty days
was chosen because one would be able to quantitate regeneration by histology to
determine advance of neurites across a gap (Ramon y Cajal, 1928b); sixty days
was chosen because the reformation of myelin should be well established
(Seilheimer et al., 1989; Wood et al., 1990).
Nine were used to assess the levels of antibody (3D12A) available in the
implants at 7 (n = 3), 14 (n = 3 ) or 28 (n = 3 ) days of survival.

The antibody

diminution was evaluated at 7 days because it has been found that at 10 days after
nerve transection, N-CAM levels were increased relative to control nerves
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(Daniloff et al., 1986b); at 14 days because in chickens, a large increase in NCAM was observed after 10 days in extracellular connective tissues (Daniloff et
al., 1986a); and at 28 days because it was found that at 20 days after nerve
transection, Schwann cells along the bands of Bungner expressed only low levels
of N-CAM (Daniloff et al., 1986b).
Recovery of Function
Physiologic assessment of recovery of nerve function was performed with
a computer-based electrodiagnostic system (Compact Four, Nicolet Biomedical
Instruments Co., Madison, WI).

Electromyographic (EMG) recordings were

made of gastrocnemius muscle contractions in response to transcutaneous
stimulation of the sciatic nerve (Kline and Kahn, 1982).

Sciatic nerves were

activated when a bipolar stimulator was applied with conductive electrode gel to
the skin over the nerve near the dorsoinedial aspect of the femur proximal to the
nerve lesion.

Supramaximal stimuli (4-12 mA) of 100 /usee duration were

applied at a rate of 2.1/sec. Muscle responses were recorded within a 10msec
time window using a band width of 5-1,500 Hz.

A concentric bipolar EMG

electrode was placed in the belly of the gastrocnemius muscle and a ground
electrode was placed subcutaneously between the stimulating and recording
electrodes.

Responses to trains of 50 stimuli were averaged twice to ensure

repeatability; the two averages were then combined.

Thus, each data point
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represents a computer average of 100 responses. Measurements consisted of the
latency to the initiation of the responses after the stimulus was applied.
Estimation of Antibody Remaining
A Non-Competitive ELISA (Weir, 1949) (Figure 1) was performed to
estimate the amounts of the original murine IgG (3D12A) that remained in the
implanted tubes 7, 14, and 28 days after surgery. A standard curve of antibody
concentration was established by coating the bottom of each well of a microtiter
plate with 50 fx\ of 1 mg/ml solution of affinity-purified rat IgG (Sigma Chemical
Co.).

One of twelve concentrations of mouse anti-rat IgG (Sigma Chemical

Co.), which ranged equally from 0.1 through 1.2 mg protein, was added to
individual microtiter wells and dried.

Bound anti-rat IgG was visualized with

orthophenaline diamine (OPD) after incubation with goat anti-mouse IgG
conjugated with horseradish peroxidase (Vector, Inc).

The optical density of

each well was read in an ELISA reader (Dynatech MR700). Each concentration
point was run six times, averaged, and plotted to produce a linear standard curve.
Contents of the implanted tubes in three animals per group were removed
and microhomogenized immediately in 90 /il of sodium phosphate buffer in
Dounce glass microhomogenizers. Triplicate samples (30 n 1) of each homogenate
were added to IgG-coated microtiter plates and incubated for 4 hours at 4°C.
After incubation in peroxidase-conjugated antibodies, each well was visualized
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coat well with antibody

incubate with sample

incubate with antibody-enzyme conjugate

add substrate and observe color change

Figure 1:
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ELISA for estim ation of antibody rem aining. Antibody-sandwich ELISA
(non-competitive assay) to detect murine IgG remaining in the implanted tubes.
A = rat IgG, B = mouse a rat IgG (our antibody), C = goat a mouse IgG,
D = HRP.
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colorimetrically as described for the standards. To estimate the amount of mouse
anti-rat N-CAM in a given animal, optical densities o f triplicate samples were
averaged.
Systemic Immune Responses to the Implants
Non-competitive ELISAs for antibody detection (Maggio, 1981; Kurstak,
1986) were performed on sera to determine whether systemic responses were
mounted against either of the two components of the implants: bovine collagen
and murine IgG (Figure 2). For these assays either 2.5 fxg mouse IgG (Sigma
Chemical Co.) or 20 y\ of collagen gel (Collagen Corp., Palo Alto, CA) was
added to microtiter plates. Serum was collected by caudal tail venipuncture from
all rats on the following days after surgery: pre-treatment (0) and 3, 7, 10, 14,
21, and 28. Thirty microliters of each serum sample were tested in each well.
Bound rat anti-mouse or rat anti-bovine IgG was visualized with orthophenaline
diamine (OPD) after incubation with goat anti-rat IgG conjugated with
horseradish peroxidase (Vector, Inc). The optical density of each well was read
in an ELISA reader (Dynatech MR700). Each concentration point was run six
times, averaged, and plotted to produce a linear standard curve. The limits of
detection of this assay are 1 to 10 ng of protein.
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ELISA for systemic im m une response. Antibody-sandwich ELISA (non
competitive assay) to detect serum immune response in operated animals. A
= mouse IgG or bovine collagen gel, B = serum (rat a mouse IgG/rat a
bovine IgG), C = goat a rat IgG, D = HRP.
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Morphological Analyses
H & E Staining
At the three survival times, animals were deeply anesthetized and
transcardially perfused for 15 minutes with a fixative (2.5% formaldehyde/0.2 %
glutaraldehyde in phosphate buffered saline (PBS)) for light microscopy as
described previously (Daniloff et al., 1986a). The portion of each sciatic nerve
containing the implant was excised, removed from the tube and post-fixed for one
hour in the same fixative. Fixed nerves were then incubated for 2 hours in 0.1
M glycine/PBS followed by an overnight incubation in 30% sucrose in PBS.
Samples were immersed in embedding compound (OCT, Miles Scientific, IL) and
quick-frozen in preparation for sectioning. Frozen sections (10 /im) of the distal
half of the nerve implant were taken on a cryostat (Riechert-Jung, 2800
Frigocut), applied to glass slides, dried and stored in a dessicator at 4°C in
preparation for antibody labeling. Several slides from the day 10 survival period
were stained with hematoxylin and eosin (Preece, 1972) to identify any cellmediated immune response generated by either the implant or our antibodies to
N-CAM.
Immunohistochemistry
For immunofluorescent double-labeling, sections were incubated in 10%
normal goat serum (NGS) in PBS for 2 hours to eliminate non-specific binding.
Sections were then incubated overnight at 22°C with polyclonal S100 antibodies

(1:100 in 10% NGS, Chemicon, Inc., Temecula, California) to label Schwann
cells (Holton and Weston, 1982a,b; Politis et al., 1982) and monoclonal
neurofilament antibodies (1:5 in 10% NGS, Dako Corp., Carpenteria, CA) to
label axons (Hofler et al., 1985).

Polyclonal antibodies were visualized with

rhodamine-conjugated goat anti-rabbit IgG (1:100 in 10% NGS, Cappel
Laboratories; Cochranville, PA).

Monoclonal antibodies were visualized by

sequential incubation in biotinylated horse anti-mouse IgG and avidin-fluoresceinconjugated goat anti-horse IgG (1:100 in 10% NGS, Cappel Laboratories).
Sections were viewed and photographed with an upright Olympus (Vanox)
photomicroscope equipped with epifluorescent capabilities and appropriate filters
for fluorescein and rhodamine optics.
Electron Microscopy
For ultrastructural analyses, animals were deeply anesthetized and
transcardially perfused with fixative (2% formaldehyde/1 % glutaraldehyde in
0.1M sodium cacodylate buffer containing 0.01M calcium chloride).

After

washing with buffer (0.1M PBS), nerves were immersed in 1% osmium
tetroxide/PBS for 1 hour at room temperature then washed. Osmicated tissues
were dehydrated in serial dilutions of ethanol before embedding in Epon/Araldite
resin.

Thick (1 fxm) and ultrathin (70 nm) sections were placed on grids and

stained with uranyl acetate and lead citrate for contrast.

Schwann cells were

identified and photographed through a Zeiss 10 transmission electron microscope.

RESULTS
A ntibody Purification

The results of attempts to purify the IgG2b with affinity chromatography
using Protein G, Protein A and Avid A/L are shown in Table 1:

Table 1
Summary of Antibody Purification by Affinity Chromatography.

Protein G

Protein A

Avid A/L

Initial Volume**
(*absorbance units)

7.329

6.750

7.467

first wash***
(*absorbance units)

2.723

3.360

3.230

% recovery****

37.2

49.8

43.3

% bound to column

62.8

50.2

56.7

glycine-HCL
pH 2.7, 1.0M

citric acid
pH 3.5, 0.1M

sodium acetate
pH 2.8, 0.05M

0.078

0.062

0.008

1.1

0.9

0.1

61.0

48.4

56.6

elution buffer

elution*** (absorbance
units)
% recovery*****

% remaining on column

*absorbance unit = (absorbance @ 280 nm)*(volume)
**volume = 3 mi
***voiume = 1.5ml
****% recovery = (first wash) + (initial volume)
*****% recovery = (elution) h- ( initial volume)
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These results indicate that using Protein G for purification allowed 62.8%
binding of the cell culture supernatant protein to the Protein G. The remainder
of the prepared mixture flowed through the column without any binding. O f the
bound IgG eluted under the manufacturer’s recommended condition (1.0 M
glycine-HCl, pH 2.7), 1.1% was eluted.
O f the applied culture supernatant proteins, 50.2% bound to the Protein
A column; again, essentially none (0.9%) of the bound IgG was eluted under the
manufacturer’s recommended condition (0.1 M citric acid, pH 3.5). In retrospect
it may be that IgG bound to the column was not eluted under the mild conditions
prescribed by the manufacturer.
A similar finding was noted with the Avid A/L fast flow column. O f the
applied cell culture supernatant protein, 56.7% bound to the beads while only
0.1% was eluted under the conditions 0.05M sodium acetate, pH 2.8.

In all

cases the eluted material (based on absorbance at 280 nm) was found to be IgG
by gel electrophoresis.

The proteins after denaturation with mercaptoethanol

migrated on 7.5% SDS-PAGE as a discreet band at 66,000 indicating the
presence of IgG (data not shown).
Anion Exchange Chromatography
IgG was ultimately purified by anion exchange chromatography using
DE52 cellulose.

Fractions eluted were assayed first by absorbance at 280 nm

and then by gel electrophoresis.

The protein after denaturation with
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mercaptoethanol migrated on 7.5% SDS-PAGE at 66,000 indicating the presence
of IgG (Hardy, 1986) (data not shown).
Antibody Characterization
Antibody Isotvping
Three clones were isotyped using the ISOSTAT Ab Kit and the following
results were found: 3B1A was found to be IgG2a, 3B1 was found to be IgM, and
3D12a was determined to be IgG2b. The clone 3B1 proved to be very difficult
to grow with viability around 20% in spite of environmental manipulation;
therefore it was not used in this study. Purified supernatant from the 3B1A clone
was used for the morphology and physiology portion of this
experiment. As a result of accidental loss, we were not able to use this clone in
additional portions of this study. The clone 3D12A was a very viable, healthy
clone which was used for the measurement of systemic immune response and for
the measurement of antibody remaining in the tubes.
Immunoblot Procedures
The 3D12A anti-N-CAM like antibody did not blot well on a Western blot
against embryonic or adult brain membrane extract. The 3B1A clone did not blot
at all. This has been reported previously (Chuong et al., 1982; Chuong et al.,
1985; Hoffman and Edelman, 1983) for N-CAM monoclonal antibodies. This
might be due to the fact that in vivo, N-CAM is membrane bound and in vitro
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(with denaturation), the conformation change in the molecule that occurs may
result in a decrease in the amount of binding sites available to the antibody.
Determination of the Molecular Weights Recognized bv the Antibodies
Radiographic analyses were performed on brain membrane proteins
resolved by
8.5% SDS-PAGE.

Results showed that the radiolabelled antibodies indirectly

identified a series of proteins very similar or identical to the embryonic form of
N-CAM. The basic protein backbone of N-CAM proteins migrates at 180,000,
140,000 and 120,000 M r on SDS-PAGE; the difference between the embryonic
and adult forms is that the embryonic form contains approximately 10 times more
polysialic acid than does the adult form (Edelman and Chuong, 1982b).

The

results of this analysis with our antibody are shown in Figure 3. It is possible
that there were other proteins present which migrate with a pattern similar to NCAM present, however, this was not determined.
Retinal Perturbation Assay
Tissues cultured in the presence of antibody (3D12A) showed disorder in
the pattern of histological layers (Figure 4).
developed in a normal manner.

In the control tissues, retinae

The commercial antibody also disrupted the

pattern of development of the chicken retinae.

Paraffin sections of retinae

cultured in the presence of antibody revealed that the organization was clearly
disrupted.

The ganglion cells, normally arranged in an even layer along the
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vitreous edge of the retina were much less organized and were found scattered
throughout the inner plexiform layer. Also, the layers consisting of the bipolar
and horizontal cells as well as the amacrine cells were not clearly distinguishable,
suggesting that the distribution of specific cell types had been altered. This is the
most widely accepted assay for demonstrating very specific immunologic
perturbation by N-CAM antibodies (Buskirk et al., 1980).
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Figure 3: Determination o f Molecular Weights Recognized by Antibodies. A. Lanes from
8.5% SDS polyacrylamide gel containing 100/ig resolved cell membrane proteins. Proteins are
labeled with MAb 3B1A (a), 3D12A (b), and visualized radiographically with iodinated second
antibodies and x-ray film. This is very similar to that described for the embryonic from o f NCAM (Chuong et al., 1982; Chuong and Edelman, 1985). B. Lanes from a Western blot of
(c) standards, (d) embryonic brain membrane extract, and (e) embryonic brain membrane
extract labeled with MAb 3D12A.
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Figure 4: Retinal P e rtu rb a tio n Assay. A. Control day 9 retina. B. Day 9 retina cultured
in the presence of the monoclonal antibody. The organization is clearly disrupted. The
ganglion cells are much less organized and are found scattered throughout the inner plexiform
layer. The layers consisting of the bipolar and horizontal cells are not clearly distinguishable.
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Muscle-Evoked Potentials
The results of muscle-evoked potential recordings are presented in Table
2.

In the experimental animals, muscle responses were absent at the 20 day

survival point. The only tested time in which experimental responses differed
significantly from controls was at 20 days. At this time there were no responses
in the experimental animals; there were responses in the animals treated with
antibodies to T hy-1. It has been previously shown that nerve regeneration in rats
sustaining a sciatic nerve transection, is normally underway by 10 days (Daniloff
et al., 1986b). This was confirmed in the present study by the observation of
muscle contractions in all o f the control animals after 20 days. After 30 days,
difference scores of experimental and control animals were similar.
Antibody Remaining in Implants
The average concentration of antibody remaining within the tubes
dissipated over a 28 day period. Approximately 45% of the total remained after
7 days, 5% remained after 14 days, and after 28 days only trace amounts were
detected.

The percentage of antibody remaining in the tubes correlated

negatively and significantly ( r = 0.95, p < .0 1 ) with the EMG response latency
differences of the gastrocnemius muscles (Table 3). There was a response in this
group of animals before the 20 day time point observed in the physiology portion
of this study.

Because Thy-1 had no apparent effect on the return of muscle

function, its diminution over time was not examined.
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Table 2
Latency (ms) between Stimulation and Initiation of Gastrocnemius Muscle
Response (Clone 3B1A, IgG2b).

Survival
(days)

20
Control

Experi
mental

II

Experi
mental

No response

2.56

Not calculated

No response

2.24

Not calculated

No response

2.04

Not calculated

No response

2.60

Not calculated

2.72

1.86

0.86

3.20

2.08

1.12

2.84

1.48

1.36

2.52

1.40

1.12

2.68

1.80

0.88

6.24

1.88

1.36

2.92

1.24

1.68

1.88

0.24

1.64

2.16

1.32

0.84

1.32

0.28

1.04

3.92

3.28

0.64

1.96

0.36

1.61

3.52

1.76

1.76

1.80

0.36

1.44

3.72

2.80

0.92

Group
mean (SD)
scores

Not
calculated

1.11 (0.25)

1.26 (0.34)

1.24 (0.57)

1.26 (0.52)
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Control

Note:

Difference
scores

30
Control

III

Normal
leg

Group
Experi
mental

1

Treated leg

1.18 (0.37)

Latency to muscle contractions (in milliseconds) for animals 20,30, and 60 days

postsurgery.

At 20 days the treated legs of all experimental animals failed to respond to

stimulation, whereas all animals were significantly slower than controls after 20 days.

Table 3
Correlation between (B) Percentage of Normal Electromyographic Response
Latencies and (C) Percentage of Original Antibody Remaining in the Implants
(Clone 3D12A, IgG2b).
(B)
Normal EMG

(A)
Survival time

(C)
% Antibody remaining

Survival time

7

34

10

0

7

56

10

0

14

6

20

83

14

4

20

83

28

0

30

98

28

0

30

99

%

Note: Corresponding survival times (A) are presented in the left-handed column.
Pearson product moment correlation coefficient, r = -0.95 (P < 0.003, r = 0.91).

Systemic Immune Response
Serum was tested 6 times from animals that were tail-bled from postsurgery day 3 to 28. There were no significant changes found in the levels of
systemic rat antibody produced in reaction to the implanted murine IgG compared
with pre-surgical serum levels (Table 4). A non-competitive ELISA was also run
at the same time periods to test for the presence of systemic rat antibodies to
bovine collagen. No significant alterations from pre-surgical levels were detected
(Table 4). These data suggest that no systemic immune responses were mounted
against either the murine IgG or the collagen component of the implants.
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Measurement of systemic response to anti-Thy-1 was not done because these
antibodies had no apparent effect on the return of muscle function.

Table 4
Immune Responses (in Optical Density Units) in Serum of Experimental Implant
Recipients after Eight Survival Points: 0 (prebleed), 3,7,10,14,20, and 28 days.
Survival day

(A)

(B)

Units

0

3

7

10

14

20

28

Mean

1162

839

897

1230

863

865

801

(SD)

(289)

(453)

(264)

(263)

(230)

(230)

(234)

Mean

151

240

220

180

170

150

260

(SD)

(141)

(190)

(200)

(180)

(170)

(180)

(150)

Note: Responses: (A) to anti-mouse IgG and (B) to bovine collagen.
Values are means and (standard deviation) o f seven animals.

H & E Staining
As shown in Figure 5, there was no obvious cell-mediated immunity as a
result of the implant or the antibodies to N-CAM. There is not more than the
occasional granulocyte or macrophage found in the following 10 day sections.
Immunohistochemistrv
Cross-sections of fixed distal nerves were taken after 10, 30 and 60
days post-surgery and stained with antibodies to visualize Schwann cells and
axons. Abnormal and frequent gaps were observed in nerves receiving antibodies
with anti-N-CAM like activity (Figure 6A).

Few Schwann cells (Figure 6A ’)

were observed and axons (Figure 6A") were not identified. In control nerves at

Figure 5: H & E staining of cross-sections of 10-day distal nerve in the tube. There was
no obvious cell-mediated immunity as a result of the implant or the antibodies to N-CAM.
Only the occasional macrophage is seen. (A) Control nerve. (B) Experimental nerve.

64
10 days of survival, as expected for severely injured nerves, gaps were present
(Figure 6B).

Schwann cells were sparse (Figure 6B’), and axons were not

observed (Figure 6B"). These findings indicate a lack of reorganization for all
groups at this time.
Nerves treated with antibodies with anti-N-CAM like activity maintained
their lack o f organization at the 30 day survival point (Figure 7A). Smaller and
less frequent gaps were present when compared to the 10 day experimental
nerves.

Morphology of control nerves, as shown in the phase contrast

photomicrograph (Figure 7B), reflected more advanced reorganization than that
shown in experimental nerves. The lack of expected reorganization 30 days after
nerve transection (Daniloff et al., 1986b; Ramon y Cajal, 1928a,b) was a
consistent finding noted only in experimental nerves.
Electron Microscopy
At this same time point, as depicted in the electron micrograph, abnormal
gaps were frequently observed between apposing Schwann cells (Figure 8).
Interactions between Schwann cells and axons were not noticeably perturbed.
After 60 days, nerves in both control and experimental nerve groups were
more reorganized (Figure 9A,B) when compared with earlier survival points.
The arrangement of Schwann cells (Figure 9A ’,B’) and axons (Figure 9A",B")
was more regular and compact than that in earlier surviving nerves.

The

appearance o f the connective tissues surrounding the distal axons (Figure 10)
suggested that myelin has been reformed around the reorganized fibers (Tanaka
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and Webster, 1991).

This reformation occurred after the time of antibody

clearance from the implants.

Figure 6:
Cross-section of distal nerves 10 days a fte r surgery.
Phase contrast
photomicrographs depict nerve morphology (A = experimental, B = control). Sections were
double-labeled with polyclonal S100 (A’,B ’) and monoclonal neurofilament antibodies (A",B").
In animals treated with experimental antibodies, gaps (g) in tissue were prevalend (A), some
S 100-positive Schwann cells (A’) were identified although no identifiable neurofilament-stained
nerves (A") were observed.
Control nerve morphology (B) depicts disarray typical of
transected nerves.
S 100-positive Schwann cells (B’) were present in the absence of
neurofilament-Iabeled regenerating axons (B"). Size bar = 50/xm.

Figure 7:
Cross-section of distal nerves 30 days a fte r surgery.
Phase contrast
photomicrographs depict nerve morphology (A = experimental, B = control). Sections were
double-labeled with polyclonal S100 (A’,B’) and monoclonal neurofilament antibodies (A",B").
Gaps (g) were still present in the experimental nerves (A), but were no longer present in control
nerves (B). Axons (white arrows), labeled by neurofilament antibodies were identified in both
control and experimental nerves at this time (A",B"). Size bar = 50/xm.

Figure 8: U ltra stru c tu ra l p h o tom icrograph o f distal experim ental nerve 30 days a fter
surgery. Electron micrograph, transverse thin section (70 nm) of experimental distal nerve.
Obvious gaps (g) between Schwann cells (s) were observed at this time point, however no
apparent abnormalities between Schwann cells and axons (a) were noted.

Figure 9:
Cross-section of distal nerves 60 days a fte r surgery.
Phase contrast
photomicrographs depict nerve morphology (A = experimental, B = control). Sections were
double-labeled with polyclonal S100 (A’,B’) and monoclonal neurofilament antibodies (A",B").
Clusterina axons (arrows) occurred in both control and experimental nerves. Schwann cells
(A’,B’) and neurofilament-labeled axons (A",B") were also present. Size bar = 50 ^m.

Figure 10: Detailed analysis of nerve m orphology at 60 days survival. Photomicrographs
of plastic embedded nerves (1 /xm thick sections) depict morphological reorganization in
experimental (A) and control (B) nerves at higher magnification.

DISCUSSION
A ntibody Pro du ctio n - U se o f Bordatella pertussis as an A djuvant

Adjuvants are nonspecific stimulators o f the immune response necessary
to induce a strong antibody response to soluble antigens.
incorporate two components.

Most adjuvants

One is a substance designed to form a deposit

protecting the antigen from rapid catabolism.

The two traditional methods of

forming a deposit are to use mineral oils or aluminum hydroxide precipitates
(Glenny et al., 1926). The second component needed for an effective adjuvant
is a substance that will stimulate the immune response nonspecifically. These
substances act by raising the level of a large set of soluble peptide growth factors
known as lymphokines. Lymphokines stimulate the activity of antigen-processing
cells directly and cause a local inflammatory reaction at the site of injection.
Heat-killed bacteria such as Bordatella pertussis or Mycobacterium tuberculosis
are the most commonly used adjuvants. The immunomodulatory mediators of B.
pertussis include a lipopolysaccharide component and the pertussis toxin (Dienes,
1936; Ellouz et al., 1974).
Antibody Purification
Anion Exchange Chromatography
The major contaminant protein in ascites fluid, serum or ammonium
sulfate precipitates, and tissue culture supernatant derived from antibodycontaining fluids is albumin, which binds DE52 tightly under conditions of low71
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to-moderate ionic strength. Antibody either fails to bind to DE52, in which case
it elutes in the void volume as the column is loaded, or it binds loosely, and can
be eluted with a gentle salt or pH gradient. Fractions eluted were assayed first
by absorbance at 280 nm and then by SDS-PAGE (data not shown).
Protein A Purification
Protein A is produced by a selected strain o f Staphylococcus aureus, is a
functionally bivalent single polypeptide and has a molecular weight of 42,000.
It has been proven to be useful in a variety of immunoassays because of its high
affinity for immunoglobulins, its low level of nonspecific binding, and its ability
to react with immunoglobulins of many different species (Kessler, 1975). The
classical Fc-binding capacity of Protein A is restricted to IgG subclasses
(Lindmark, et al., 1983), except for other human classes of Ig which have been
variably shown to bind to Protein A mediated by Fab structures (Bjorck and
Kronvall, 1984). This alternative Fab-mediated Ig binding is of low avidity, and
will show up when Protein A is present in excess in relation to IgG-Fc structures
(Inganas, 1981).
Protein A consists of six different regions, five of which show strong,
specific binding for the Fc-part of IgG of many mammalian IgG subclasses,
leaving the antigen-binding sites free (Kessler, 1976).

Immobilized Protein A

can bind at least two molecules of IgG per molecule. When Protein A sites were
provided in excess over IgG sites, virtually all IgG antibody molecules purified
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from a hyperimmune rabbit antiserum against BSA bound firmly to the adsorbent
(Kessler, 1976). Some monoclonal antibodies have a low affinity for Protein A,
such as some mouse IgG, and human IgG3 monoclonal antibodies (Larsson and
Holmdahl, 1990).
Affinity chromatography on Protein A columns is widely used for the
purification of monoclonal antibodies (Larsson and Holmdahl, 1990).

The

antibodies are normally applied to the column at neutral pH or at pH 8-9 and
eluted at a lower pH.

Application at a higher pH will increase the binding of

some mouse antibodies to the column (Ey et al., 1978). Mouse IgG is eluted
from Protein A columns between pH 7.0 and 3.5 (Lindmark et al., 1983),
however a low pH will inactivate some monoclonal antibodies. In this project,
only 50.2% of the IgG present in the ascites did indeed bind strongly to the
Protein A.

The capacity of this column was not exceeded, therefore the

conditions for binding should have been optimized.
Individual monoclonal antibodies are found which do not conform to the
general rules. Some hybrids which secrete antibodies give rise to partially active
or inactive forms of the general form AA, AB, BB, where A and B are the two
different (active and inactive) heavy chains which will be present in the ratio
1:2:1. Since different subclasses or microheterogeneity may be represented by
the individual heavy chains, it follows that they may be resolved into three peaks
or a broad Protein peak. The primary Protein A binding site on IgG is probably
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present in the intact CH2-CH3 region of the heavy chains. If either chain of the
pair is damaged or missing, then affinity will be reduced (Jack, 1990).
Conversely, if aggregates or polymers are present, then affinity may be
increased. These situations are manifest by minor peaks eluting earlier or later
than the main peak. Other binding sites in the IgG molecules are occasionally
seen, though these are weaker and more variable in occurrence (Zola, 1990).
In retrospect, it appears that while our antibody bound to the column, it
did not elute (% recovery = 1 . 1 ) with a 0.1 M citric acid buffer, pH 3.5. It has
been shown in a study where PBS, pH 8.0 was used to wash the column
following application of serum, no IgG2 was found in the effluent even after
prolonged washing. Elution of bound IgG with 0.58% acetic acid confirmed that
the IgG2 had been retained on the column (Ey et al., 1978).

These results

indicated that binding of IgG2 to Protein A could occur and that the association
constant for this binding was extremely pH-dependent. In this referenced study,
IgG, was eluted at pH 6.0, IgG2a eluted at pH 5.0 while IgG2b was not eluted
until the buffer was at pH 3.0 - 4.0 (Ey et al., 1978).
The reason for the low apparent recovery of IgG2b in the present study is
not known.

We did not have evidence of non-binding of IgG to the column.

Fractions were collected directly into tubes containing 1 M Tris-HCL buffer (pH
9.0) to immediately neutralize the eluate.

Therefore, acid denaturation was

probably not a factor. It is possible that some IgG2b was lost through digestion
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by contaminating protease(s), as mouse IgG2b has been shown to be more
sensitive than IgG, to proteolytic cleavage (Dessanayake and Hay, 1975).
Protein G Purification
Protein G-Sepharose chromatography offers a rapid method of purifying
most subclasses of IgG. Protein G (Pharmacia, LKB) is a cell-surface protein of
group G Streptococci and can be used to purify human, rat and mouse IgG. It
is similar to Protein A in that it binds the Fc portion of the immunoglobulin.
The capacity of Protein G is higher than that of Protein A. The absorbance at
280nm of 2.224 of the initial 3 ml sample indicated a protein concentration of 1.6
mg/ml. The capacity of the Pharmacia MAbTrap™ Fast Flow column was 6-7
mg/ml of gel. Since approximately 4.8 mg protein was applied to a 1 ml bed
volume, the capacity of the column was not exceeded (80%). It was noted that
approximately 62.8% of the applied protein bound to the column, however, after
elution with 1.0M glycine-HCl, pH 2.7, 61.1% of the original material bound
remained on the column.
Avid AL™ Purification
The binding capacity for IgG2h from mouse for Avid AL is 5-7 mg IgG/ml
of gel.

Three mis of concentrated cell culture supernatant with an IgG

concentration of 1.4 mg/ml (as determined by absorbance at 280 nm) were
applied to this column; therefore approximately 4.2 mg of IgG was applied to a
1 ml column.

The capacity of the column was at 70% which should have
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allowed for maximum Fc binding. Approximately 56.7% of the IgG bound to
the column, however, it did not elute under the conditions of 0.05 M sodium
acetate buffer, pH 2.8 as recommended by the manufacturer of the kit.

The

elution fraction was collected at 280 nm and was determined to be IgG by gel
electrophoresis. It is possible that the same variables as discussed in the previous
two sections occurred and further studies as to possible elution methods are
warranted.
Antibody Characterization
Determination of Molecular Weights
Gels have been widely used as the medium for immunoblot procedures.
In this study, the radiolabeled anti-N-CAM like antibody recognized a broad band
at MW 140,000 and minor bands at MW 180,000 and 120,000 when incubated
with rat brain membrane extract on nitrocellulose. This pattern is similar to that
of chicken N-CAM (Daniloff et al., 1986b); this lead to the assumption that the
antibody in question did have anti-N-CAM like activity.
Retinal Perturbation Assay
Anti-N-CAM antibodies alter the appearance of histotypic patterns in
retinal cell aggregates maintained in culture for several days (Rutishauser et al.,
1978). It has also been found that the antibodies can disrupt histogenesis of the
developing retina in organ culture (Buskirk et al., 1980). In the chick, cell and
plexiform layers of the central portion of the retina are formed between the sixth
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and ninth days of embryonic life (Kahn, 1974). Retinae dissected from chicken
embryos on day 6 and placed in organ culture for 3 days undergo histogenesis
similar to that which occurs in vivo.

Our results demonstrate that our

monoclonal antibodies have anti-N-CAM like activity and disrupted the internal
development of a tissue never subjected to mechanical dissociation.

Because

individual cells in the anti-N-CAM-treated retinae were morphologically similar
to those in the control tisssues, it seems that the effects are not simply a
consequence of changes in the developmental pathway of individual cells (Buskirk
et al., 1980). This conclusion was supported by the ability of the anti-N-CAM
treated retinae to form some histological layers which, although altered, could be
directly identified with layers in the normal retina (Buskirk et al., 1980). Since
the application of the monoclonal antibody used in this study disrupted the
organization of the retina as shown in Figure 4, it can be assumed that our
antibody had anti-N-CAM like activity, however, the possibility exists that our
antibodies recognized other cell adhesion molecules and simply cross-reacted with
N-CAM.
Use of Thv-1 Antibodies as Control
Thy-1 has been identified on almost every type of neuron and axon in the
peripheral nervous system of the rat: sympathetic and parasympathetic ganglion
cells, interneurons in sympathetic ganglia, preganglionic sympathetic axons,
sensory ganglion cells and motor axons (Morris et al., 1985). Thy-1 is a major
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glycoprotein of the neuronal surface; it has been estimated that Thy-1 constitutes
2.5-7.5% of the surface protein of the following axons: myelinated CNS axons
of the optic nerve, large myelinated motor axons of the hyposlossal nerve and the
small, unmyelinated axons of the preganglionic sympathetic chain (Beech et al.,
1983). Thy-1 has not been found on glial cells in normal adult nervous tissue
(Mirsky and Thompson, 1975).

It has also been found that Thy-1 antibodies

coated as a substrate on a culture dish promoted neurite outgrowth by Thy-1positive neurons [retinal ganglion cells (Leiffer et al., 1984) and Purkinje cells
(Messer et al., 1984)]. In the present study, antibodies to Thy-1 protein, which
have affinity for the surface of cells derived from the brain in addition to the
thymus (Campbell et al, 1981), were used in control tubes. Antibodies to Thy-1
were used as controls: (1) for steric hindrance and (2) because the protein has no
known contribution to the growth or adhesion of nerves in vivo (Letarte, 1984).
Muscle Evoked Potentials
Electromyographic latencies were used as a non-invasive estimate of nerve
patency.

Our non-invasive recordings only approximated nerve conduction

velocity, which can be correlated directly with the number of rapidly conducting
nerve fibers and the degree of myelination of the nerve (Gibson et al., 1989a).
However, recordings of conduction velocity by direct exposure and stimulation
of the nerves would have precluded the planned ultrastructural and morphological
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examination of the tissues. The reproducibility of the latency recordings was the
primary rationale for its use in these experiments.
The latency data (Table 2) showed that regeneration was significantly
perturbed at 20 days after implantation. No muscle contractions were evoked in
experimental animals but responses were evoked in all controls.

This is a

particularly relevant observation because it has previously been shown that active
regeneration is present in rodents by 10 days (Daniloff et al., 1986b). This lack
of response in experimental nerves was no longer present at 30 days post
surgery.

Although the average response for experimental animals was slower

than that of controls at 30 days, the differences were not statistically significant.
The validity of this analysis is enhanced because normal responses of
contralateral (unoperated) legs were used as internal controls.

There was no

evidence of any experimental perturbation after 60 days.
Antibody Remaining in Implants
Perhaps a unique aspect of this investigation was the quantitation of NCAM antibody levels remaining in the tubes during various stages of survival.
Results indicated a progressive disappearance of the N-CAM antibody from seven
days post-surgery, when approximately 45% remained, to twenty-eight days,
when only trace amounts were detected.

It is unclear why there were muscle

responses in this group before 30 days.

It is conceivable that this was due to

individual animal variability.

Another explanation may be that there was a
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difference in antibody activity between clones 3B1A used in the physiology
experiment and 3D12A used in this experiment.

The non-competitive

immunoassay (Maggio, 1981; Kurstak, 1986) was used because of its high
sensitivity in detecting small quantities of immunoglobulin.

The limits of

detection of this assay are 1 to 10 ng of protein.
Systemic Immune Response
This non-competitive assay was also used to determine that no systemic
immune responses were mounted against the contents of the tubes. There was
no evidence that antibodies to bovine collagen or murine IgG were present in the
serum of the experimental animals, suggesting that the steady decline of antibody
in the implants was not linked to immunologic clearance by reactive cells. NCAM does not circulate in peripheral blood because it is a cell surface adhesion
molecule specific for neurons and glia; therefore the presence of any systemic
antibody would have been due to the presence of antibodies used in our implants.
It is possible that the contents of the tubes were mechanically displaced by
migrating Schwann cells or advancing nerve fibers.
Immunohistochemistrv and Electron Microscopy
In cross-sections of the 10 day experimental nerves, abnormal nerve gaps
predominated. These gaps were larger and more frequent than gaps in control
nerves. In the present study, control nerve morphology did not differ from that
described by others (Daniloff et al., 1986b; Gibson et al., 1989b; Ramon y
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Cajal; 1928b).

The appearance of gaps in nerve tissues severely injured by

transection has been described as an expected component of the initial stages of
regeneration (Ramon y Cajal, 1928b).

This led us to conclude that the

application of our antibody with anti-N-CAM like activity interfered with the
normal abilities of injured nerves to regenerate by blocking cell binding mediated
by N-CAM.
At 30 days post-surgery,
anticipated reorganization.

morphology of control nerves reflected

This was depicted by the absence of gaps and the

presence of axons in the distal stump. In experimental nerves, gaps, specifically
between apposing Schwann cells, continued to be observed. No disruptions were
observed between Schwann cells and axons. In the companion physiologic study,
we found that the disruption of functional recovery was temporary and that by
30 days after surgery, somatic muscle control approached that of control nerves.
The present data offer a rationalization for the observed perturbation of
function seen in early stages with muscle-evoked potentials. Furthermore, since
antibodies

disrupted

only

Schwann

cell-Schwann

cell

interactions,

the

contributions of N-CAM to the process of regeneration may be through selective
control of Schwann cell-Schwann cell adhesion. Morphological analyses of the
thick sections taken at 60 days post-surgery suggest that myelin may be present
in control nerves and to a lesser extent in experimental nerves. It remains to be
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proven whether N-CAM is involved with the reformation of myelin, in addition
to the growth of nerves and their responses to injury.
The availability of the N-CAM has been shown to be an essential
component of the complex process of nerve regeneration. Since antibodies with
anti-N-CAM like activity perturb regeneration, N-CAM potentially contributes
to this process. The effect shown here can only be applied to the initial stages
of regeneration and the contribution of N-CAM to later stages of regeneration
remains to be shown.

CONCLUSIONS
Many studies have been done to determine substances available to aid in
peripheral

nerve regeneration.

These include studies of the following

compounds: laminin, fibronectin and collagen, growth factors, and cell adhesion
molecules. All of these compounds are known to be involved at some stage of
peripheral nervous system or central nervous system development; as such they
have been implicated in regeneration.
Laminin is an integral basal lamina protein while fibronectin is a major
component of basal lamina, connective tissue and extracellular matrix produced
by fibroblasts. Growth factors support differentiation, maturation and survival
of sympathetic and primary sensory neurons. NGF is involved in regulation of
adhesion molecule expression (Thoenen and Barde, 1980).
External factors found to play a role in peripheral nervous system
regeneration are the effect of a conditioning lesion or the application of a pulsed
electromagnetic field to an animal. The conditioning lesion increases the rate of
regeneration (Oblinger and Lasek, 1984; Sjoberg and Kanje, 1980); (1) by
changes in non-neuronal cells, and trophic factor production due to Wallerian
degeneration in the distal nerve and (2) the nerve cell body has already made
necessary adjustments and axons have synthesized materials necessary for
regeneration. The application of a PEMF was found to influence the synthesis
of new polypeptides in rat sciatic nerve (Sisken et al., 1989a).
83
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In this study implants containing anti-N-CAM-like antibodies disrupted
nerve regeneration between 10 and 30 days post-surgery. This affect appears to
no longer be present in long-term (60 day) survivors. Muscle-evoked potentials
appear to be a reliable way to estimate the extent of nerve regrowth. They are
a non-invasive method of determining return of muscle function. We found that
at 20 days, there was no return of muscle function as determined by comparing
MEPs of control vs experimental nerves.
No significant changes were found in the levels of systemic rat antibody
produced in reaction to the implanted murine IgG compared to pre-surgical
levels. The presence of systemic rat antibodies to bovine collagen was not noted.
These data suggest that no systemic immune responses were mounted against
either the murine IgG or the collagen component of the implants.
No cell-mediated immunity was noted in the H & E stained distal nerve
sections at the 10 day time periods indicating that macrophage clearance of
antibody from the implant was not a major factor in the return of function seen
at 30 days.
Immunohistochemistry at 10 days indicated that no neurofilaments were
regrowing through the implant at this time.

At 30 days, coinciding with the

return of somatic muscle function, neurofilaments were beginning to be seen in
the distal nerve. Electron micrographs confirm that gaps were present between
Schwann cells and not between Schwann cells and axons. This implied that N-
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CAM mediated Schwann cell-Schwann cell interactions in regenerating peripheral
nerves and not Schwann cell-axon interactions.

Since anti-N-CAM like

antibodies perturbed regeneration temporarily, and Schwann cells are necessary
for nerve regeneration, anti-N-CAM like antibodies disrupted this regeneration
possibly by interacting directly with Schwann cell adhesiveness to each other.
By blocking the N-CAM protein to perturb regeneration, we established its
potential contribution to the general process.
The implantation of the antibody in this study around transected adult
sciatic nerves delayed the reinnervation of target muscles for a period of between
twenty and thirty days.

No systemic immune responses to the implants were

detected, however, electrophysiological recordings of the normal nerve indicate
that there was a systemic effect at 20 days. It is possible that minute quantities
of circulating antibodies disrupted Schwann cell-Schwann cell or Schwann cellaxon interactions in normal nerves.

Since N-CAM is localized to nodes of

Ranvier and the neuromuscular junction, and possibly related to maintenance of
mature function, systemic antibody may have affected transmission at a distance
as suggested by the latency data. This effect was no longer present at 30 days.
These data implicate cellular interactions mediated by N-CAM, at least during
the early stages of regeneration, as potential components of the regeneration
process.
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These results are strengthened by three observations from studies of
surgical repair of nerve damage. Entublization of transected nerves with inert
plastic has been shown to be an excellent method of intervention (Gibson and
Daniloff, 1989a). It has also been shown that silastic tubes are more effective
enhancers of early mammalian nerve regeneration than three other commonly
used surgical methods (Gibson, et al., 1989b). Furthermore, it has been shown
that substrates such as laminin and collagen enhance rodent nerve regeneration
(Gibson, et al., 1989b).

Therefore, the conditions of our entubulization

procedure should have enhanced the potential for nerve regeneration in every
animal, except for one factor: the antibody with anti-N-CAM like activity.
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A P P E N D IX A

Reagents and Gel Preparation for SDS-PAGE Slab Gels
Reference: Laemmli, 1970

A.

Acrylam ide/Bis (30% T, 2.67% C)(AMRESCO, Solon, OH)
146 g acrylamide (29.2 g/100 ml)
4 g N ’N ’-Bis-methylene-acrylamide (0.8 g/100 ml)
Make to 500 ml with distilled water. Filter and store at 4°C in the dark
(30 days maximum).
Or substitute Bio-Rad Preweighed Acrylamide/Bis 37.5:1 mixture (Catalog
No. 161-0112 30g)(Catalog No. 161-0106 200g).

B.

1.5M T ris-H C L , p H 8.8 - separating gel buffer
for 100 ml:
18.15 g Tris base (TRIZMA)
90 ml millipore distilled water
Adjust to pH 8.8 with concentrated HCL. Make to 100 ml with distilled
water and store at 4°C.

C.

0.5M T ris-H C L , p H 6.8 - stacking gel buffer
for 100 ml:
6.0 g Tris base (TRIZMA)
80 ml millipore distilled water
Adjust to pH 6.8 with concentrated HCL. Make to 100 ml with distilled
water and store at 4°C.
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D.

A m m onium Persulfate, 10%, (Bethesda Research Laboratories,
Gaithersburg, MD)(Catalog No. 5523UA, Lot No. ACD209).
Make immediately prior to using:
0.1 g ammonium persulfate
0.9 ml distilled water

E.

Sodium Dodecyl Sulfate - 10%
5 g SDS; make to 50 ml with distilled water.

F.

T E M E D (AMRESCO, Solon, OH; Catalog No. P0076156, Lot No.
188011)
use at room temperature, add just before ammonium persulfate

G.

10X Electrode B uffer - for running electrophoresis in tank
Tris (TRIZMA, trisbase)
Glycine
SDS

90 gm
432 gm
30 gm

Make to 3 liters with distilled water. Dilute 100 ml to 1 liter for one run.

A P P E N D IX B

Western Blot on Nitrocellulose Paper
Reference: Towbin et al., 1979

Reagents:

Biotinylated Goat anti-mouse
Cappel #8711-3731

Organon Teknika Corp.
1230 Wilson Drive
West Chester, PA 19380

Streptavidin-horseradish peroxidase
KPL #143000

Kirkegaard & Perry, Inc.
2 Cessna Court
Gaithersburg, MD 20878

Solutions:
a.

EPBS (ELISA phosphate buffered saline)
solution A

4 liters

solution B

1 liter

NaCl
kh,po4
kcL

8.0 g
1-3 g
0.8 g

KCL
NaCl
Na2H P 0 4

0.2 g
32.0 g
5.4 g

Make up solution A and solution B in distilled water. Add solution
B to solution A until pH reaches 7.4 (approximately 125 ml of
solution B to 500 ml of solution A). Filter sterilize.
b.

Substrate
1.
2.
3.
4.

Add 22.5 ml distilled water to 2.5 ml 0.5 M Tris-HCl (pH
6 . 8 ).
Add 15 mg 4-chloro-l-napthol in 5 ml methanol.
Add 10 ul 30% hydrogen peroxide.
Test substrate in streptavidin and add 2-4 ul peroxide if too
weak.
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c.

Alternate Substrate TMB Membrane Peroxidase Substrate System
(3,3 ,5,5 -tetramethylbenzidine)
Kirkegaard & Perry, Inc., Gaithersburg, MD
catalog # 50-77-00

Procedure:
a.

Block strips with 2 ml per lane of EPBS with 10% NGS for 1 hour on rocker
platform.

b.

Wash twice with EPBS (no additives) on rocker platform, 2 ml per lane.

c.

Put 2 ml per lane of monoclonal supernatants on and incubate on rocker
platform overnight. Do not dilute supernatants.

d.

Wash 5 times with 2 ml per lane EPBS, 5 minutes for each wash.

e.

Put on 1 ml per lane Cappel goat anti-mouse biotinylated 2nd antibody made
in EPBS plus 10% goat serum (1:500 dilution) and incubate for 3 hours on
rocker platform.

f.

Wash 5 times with 2 ml per lane EPBS, 5 minutes for each wash.

g.

Put on 1 ml per lane Streptavidin-Horseradishperoxidase made in EPBS plus
10% goat serum (1:750 dilution) and incubate for 1.5 to 2 hours on rocker
platform.

h.

Wash 5 times with 2 ml per lane EPBS, 5 minutes for each wash.

i.

Add 1 ml per lane substrate and wait until color is of desired intensity.

j.

Wash with distilled water and let dry.

A P P E N D IX C
R ecipes for H iTrap™ Protein A Affinity Colum n

Source:

Pharmacia LKB Biotechnology, Inc.
Piscataway, NJ 08855
Code No. 17-0402-01
Lot No. RC 13916

Reference:

Kessler, S.W. 1975,1976; Richman et al., 1982.

Buffer A:

wash buffer
50 mM Tris, pH 8.6
Dissolve 3.03 gm Tris into 500 ml distilled H-,0. Adjust pH
with IN HCL to pH 8.6.

Buffer B:

elution buffer
0.1 M citric acid, pH 3-6
Dissolve 2.94 gm citric acid into 100 ml distilled H20 .
Adjust pH with concentrated (6N) HCL to 3.1.

Buffer C:

neutralization buffer
1.0 M Tris, pH 9.0
Dissolve 12.11 gm Tris into 100 ml distilled H ,0 . Adjust pH
with IN HCL to 9.0.

All buffers should be filter sterilized (0.45 jum) before application to the
column.
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A P P E N D IX D
R ecipes for M A bTrap™ G Affinity C hrom atography

Source:

Pharmacia LKB Biotechnology, Inc.
Piscataway, NJ 08855
Code No. 17-0701-01
Lot No. TOA003

Reference:

Bjorck and Kronvall, 1984

Buffer A:

binding buffer
0.2 M sodium phosphate, pH 7.0
Dissolve 2.4 gm NaH2P 0 4 into 100 ml distilled H20 . Adjust
pH with IN HCL to 7.0.

Buffer B:

elution buffer
1.0 M glycine-HCL, pH 2.7
Dissolve 75 mg glycine into 100 ml distilled H ,0. Adjust pH
with IN HCL to 2.7.

Buffer C:

neutralizing buffer
1.0 M Tris-HCL, pH 9
Dissolve 12.11 gm Tris into 100 ml distilled H20 . Adjust pH
with 1.ON HCL to 9.0.

All buffers should be filter sterilized (0.45 jam) before application to the
column.
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A P P E N D IX E
R ecipes for Avid AL M ini-C olum n

Source:

BioProbe International, Inc.
The Nest Group
43 Valley Road
Southboro, MA 01772
800-347-6378
Catalog No. 5325-003, Lot No. 1-071-2

References:

Khatter et al., 1991; Fiiglistaller, 1989; Gassmann et al., 1990.

Buffer A:

wash buffer
0.01 M sodium phosphate, 0.15 M sodium chloride, 0.02%
sodium azide, pH 7.4
Dissolve 0.23 gm NaH2P 0 4 (1.9 mM) and 1.15 gin Na2H P 0 4
(8.1 mM) and 9.0 gm NaCl (154 mM) into 1 liter of distilled
H20 . Adjust pH to 7.4 with IN HCL.

Buffer B:

elution buffer
0.05 M sodium acetate, pH 2.8
Dissolve 0.68 gm sodium acetate into 75 ml of distilled H20
water.
Add 25 ml glycerol.
Adjust pH to 2.8 with
concentrated (6N) HCL.

Buffer C:

regeneration buffer
20 parts methanol, 80 parts 1% acetic acid
Add 5 nils of glatial acetic acid to 495 mis of distilled H20 .
Take 400 mis of this mixture and add 100 mis of methanol.

Buffer D:

neutralizing buffer
1.0 M Tris Base, pH 9.0
Dissolve 12.11 gm of Tris into 100 mis of distilled H20 .
Adjust pH to 9.0.

All buffers should be filter sterilized (0.45 jum) before putting on the column.
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A P P E N D IX F

DEAE-Cellulose Anion Exchange Chromatography

Source:

Whatman Specialty Products Division
P O Box 1359
Hillsboro, OR 97123-9981
Catalog No. 4057P050
Batch No. 1152012

Reference: Fahey and Terry, 1979; Miller et al., 1991.

Buffer 1)

Buffer 2)

10X 0.175 M N aP04, pH 6.3
a)

Dissolve 26.8 gm NaoHP04 in 500 mis of distilled H20 .

b)

Dissolve 55.2 gm NaHoP 0 4 in 2000 mis of distilled
H20 .

c)

Take 440 mis of A, add 1560 mis of B and add 280 mis
of distilled H20 .

d)

Adjust pH to 6.3 with IN HCL.

0.175 M N aP04 plus 0.05 M NaCl, pH 6.3
a)

Make PBS as above buffer 1.

b)

Add 2.92 gm NaCl/liter of buffer.

c)

ADjust pH to 6.3 with IN HCL.

* All buffers should be filtered (0.45 ^tm) before application to a column.
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